{"gene":"MTTP","run_date":"2026-06-10T05:19:51","timeline":{"discoveries":[{"year":1998,"finding":"Small molecule inhibitors of MTP prevent assembly and secretion of apolipoprotein B-containing lipoproteins in rodent models, establishing MTP as essential for VLDL/chylomicron production and demonstrating that pharmacological inhibition normalizes plasma lipoprotein levels in WHHL rabbits.","method":"High-throughput screening for MTP inhibitors; in vivo treatment of rodent models and WHHL rabbits with compound 9","journal":"Science","confidence":"High","confidence_rationale":"Tier 1/2 / Strong — in vitro MTP inhibition assay combined with in vivo animal model, replicated across multiple species with clear mechanistic readout","pmids":["9784135"],"is_preprint":false},{"year":1999,"finding":"Hepatic overexpression of MTP via recombinant adenovirus in mice results in increased microsomal triglyceride transfer activity, elevated plasma TG, and significantly higher VLDL-TG and VLDL-apoB secretion rates, establishing MTP as rate-limiting for VLDL apoB secretion under basal conditions.","method":"Adenoviral hepatic overexpression of MTP in C57BL/6 mice; in vivo measurement of hepatic TG secretion rates and VLDL apoB secretion","journal":"Journal of lipid research","confidence":"High","confidence_rationale":"Tier 2 / Strong — clean gain-of-function in vivo with quantified mechanistic readout (secretion rates), multiple lipid parameters measured","pmids":["10553017"],"is_preprint":false},{"year":2000,"finding":"MTP physically interacts with apoB, and a compound (AGI-S17) that specifically inhibits apoB-MTP binding (without affecting MTP lipid transfer activity) reduces apoB secretion by 70-85% in HepG2 cells, identifying two functionally independent domains in MTP: an apoB-binding (chaperone) domain and a lipid transfer domain.","method":"Competitive binding assays with apoB peptides and MTP; co-immunoprecipitation in HepG2 cells; selective inhibitor (AGI-S17 vs BMS-200150); apoB secretion measurement by pulse-chase","journal":"Biochemistry","confidence":"High","confidence_rationale":"Tier 2 / Strong — reciprocal inhibitor approach distinguishing two functional domains, co-IP in cells, secretion assay with multiple controls","pmids":["10769147"],"is_preprint":false},{"year":2001,"finding":"MTP binds lipid vesicles to form stable MTP-lipid complexes in the ER lumen; binding of MTP to zwitterionic phospholipids increases its affinity for apoB100 2–4-fold, while negatively charged lipids decrease apoB-MTP interactions. Stable MTP-lipid complexes are detected in microsomal fractions of COS cells, HepG2 cells, and mouse liver.","method":"In vitro lipid binding and protein-protein interaction assays; ultracentrifugation of microsomal contents; binding affinity measurements with apoB truncation constructs","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 / Strong — in vitro reconstitution of MTP-lipid complexes plus cellular fractionation, multiple apoB constructs tested, results replicated in three cell/tissue systems","pmids":["11427523"],"is_preprint":false},{"year":2005,"finding":"Conditional intestine-specific deletion of Mttp in villus enterocytes abolishes chylomicron assembly and secretion, causes enterocyte lipid droplet accumulation (steatorrhea), and dramatically reduces apoB48 secretion; hepatic lipogenesis and VLDL secretion increase compensatorily, establishing MTTP as essential for intestinal chylomicron assembly.","method":"Tamoxifen-inducible intestine-specific Cre-lox knockout (Mttp-IKO); electron microscopy; in vivo chylomicron secretion assays; primary enterocyte apoB48 secretion","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 2 / Strong — clean conditional KO with multiple orthogonal phenotypic readouts and in vivo/in vitro validation","pmids":["16354657"],"is_preprint":false},{"year":2007,"finding":"MTP (via a novel splice variant MTPv1 expressed from an alternate promoter in thymocytes) transfers phosphatidylethanolamine to CD1d in vitro and is required for NKT cell development; MTP inhibition in fetal thymic organ culture abolishes CD1d tetramer-positive cell generation and IL-4 production, while CD1d surface expression is unaffected.","method":"PCR/Northern analysis identifying MTPv1; Edman degradation of isolated MTPv1; in vitro phospholipid transfer to CD1d; fetal thymic organ culture with MTP antagonists; flow cytometry for CD1d tetramers","journal":"The Journal of experimental medicine","confidence":"High","confidence_rationale":"Tier 1/2 / Strong — in vitro lipid transfer reconstitution to CD1d, loss-of-function FTOC experiment, multiple orthogonal methods in single study","pmids":["17312007"],"is_preprint":false},{"year":2008,"finding":"IRE1β (but not IRE1α) selectively degrades MTP mRNA via increased posttranscriptional degradation in enterocytes, thereby reducing intestinal MTP expression and chylomicron production; Ire1b−/− mice secrete more chylomicrons and express more intestinal (but not hepatic) MTP.","method":"Ire1b−/− mouse model; diet challenge; primary enterocyte isolation; cell culture siRNA knockdown of IRE1β; quantification of MTP mRNA stability and chylomicron secretion","journal":"Cell metabolism","confidence":"High","confidence_rationale":"Tier 2 / Strong — genetic KO with in vivo phenotype, primary cells, and cell culture mechanistic follow-up; IRE1α/β specificity established","pmids":["18460335"],"is_preprint":false},{"year":2010,"finding":"The circadian clock gene CLOCK upregulates SHP (NROB2) expression by binding to its E-box; SHP then suppresses MTP expression by binding to HNF4α/LRH-1 at the MTP promoter, establishing a CLOCK→SHP→MTP axis that drives diurnal oscillation of plasma triglyceride-rich lipoproteins.","method":"Clock mutant mice (Clock mt/mt); CLOCK knockdown; SHP knockout mice (Shp−/−); serum-shock cyclic expression assay; promoter binding and siRNA experiments; rescue of hypertriglyceridemia by SHP expression","journal":"Cell metabolism","confidence":"High","confidence_rationale":"Tier 2 / Strong — multiple genetic models (KO, knockdown, mutant), epistasis rescue experiment, promoter interaction studies, replicated in vivo phenotype","pmids":["20674862"],"is_preprint":false},{"year":2012,"finding":"The IRE1α-XBP1s arm of the UPR regulates hepatic VLDL assembly: hepatocyte-specific Ire1α deletion reduces MTP activity (without affecting TG synthesis or apoB synthesis/secretion) due to decreased PDI expression, impairing lipid partitioning into the ER lumen and TG-rich VLDL assembly.","method":"Hepatocyte-specific Ire1α knockout mice; MTP activity assays; de novo lipogenesis measurements; apoB synthesis/secretion assays; PDI expression analysis","journal":"Cell metabolism","confidence":"High","confidence_rationale":"Tier 2 / Strong — conditional KO with mechanistic dissection of multiple pathway steps, multiple orthogonal readouts, establishes IRE1α-XBP1s-PDI-MTP axis","pmids":["23040069"],"is_preprint":false},{"year":2012,"finding":"NR2F1 suppresses synergistic activation of the MTTP promoter by HNF-4α/HNF-1α by binding to a direct repeat 1 (DR1) element and recruiting nuclear receptor corepressor 1 (NCoR1), without affecting activities of the individual transcription factors; HNF-4α is required for basal MTTP expression.","method":"MTTP promoter-reporter (luciferase) assays; EMSA; co-transfection of transcription factors in intestinal cell lines","journal":"Journal of lipid research","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — promoter-reporter and EMSA in cell culture, single lab, mechanistically defines a novel repression mechanism","pmids":["22357705"],"is_preprint":false},{"year":2014,"finding":"FoxO6 directly binds the MTP promoter and stimulates MTP expression and VLDL-TG secretion; insulin inhibits this by phosphorylating FoxO6 to disable DNA binding. Hepatic FoxO6 inhibition in insulin-resistant db/db mice suppresses MTP expression and reduces hypertriglyceridemia.","method":"Transgenic and knockdown mouse models; promoter binding assays (ChIP-like); MTP promoter-reporter assays with FoxO6 site mutations; primary human hepatocytes; insulin signaling assays in db/db mice","journal":"Endocrinology","confidence":"High","confidence_rationale":"Tier 2 / Strong — gain-of-function and loss-of-function in multiple models (transgenic mice, KD, db/db), promoter mutagenesis, functional rescue, and primary human cells","pmids":["24437489"],"is_preprint":false},{"year":2015,"finding":"SAP18 is a novel binding partner of TRIB1 that regulates MTTP expression; SAP18 and TRIB1 co-occupy MTTP regulatory sequences along with mSin3A; SAP18 knockdown decreases and overexpression increases hepatic MTTP expression and plasma lipid levels.","method":"Yeast two-hybrid screen; adenoviral overexpression/knockdown in mouse liver; chromatin immunoprecipitation; transcriptome analysis","journal":"Journal of lipid research","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — ChIP, in vivo gain- and loss-of-function, single lab with multiple methods","pmids":["25921304"],"is_preprint":false},{"year":2017,"finding":"Loss of MTTP activity (MTTPR46G mutation) in iPSC-derived hepatocytes and cardiomyocytes abolishes apoB secretion and causes intracellular lipid accumulation and increased cell death in cardiomyocytes; correction of the mutation by CRISPR/Cas9 rescues these phenotypes, demonstrating a cell-autonomous requirement for MTTP in both cell types.","method":"Patient-derived iPSCs with MTTPR46G mutation; differentiation to hepatocytes and cardiomyocytes; CRISPR/Cas9 correction; apoB secretion assays; lipid staining; cell death assays","journal":"Cell reports","confidence":"High","confidence_rationale":"Tier 2 / Strong — isogenic CRISPR rescue controls in two cell types, multiple functional readouts, clean loss-of-function with genetic correction","pmids":["28514664"],"is_preprint":false},{"year":2020,"finding":"PRAP1 is a novel lipid-binding protein that directly binds TG and forms a ternary complex with TG and MTTP in the ER; a single amino acid mutation (E85V) that disrupts ternary complex formation impairs MTTP-mediated apoB-containing lipoprotein assembly and secretion. PRAP1-deficient and E85V knock-in mice show reduced lipid absorption and resistance to diet-induced obesity.","method":"Co-localization in ER; in vitro lipid transfer assays; ternary complex formation assays; site-directed mutagenesis (E85V); PRAP1-KO and knock-in mouse models; high-fat diet challenge","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 / Strong — in vitro reconstitution of ternary complex, mutagenesis, and multiple in vivo genetic models with clear mechanistic phenotype","pmids":["33168624"],"is_preprint":false},{"year":2020,"finding":"In liver-specific MTTP knockout (L-Mttp−/−) mice, hepatic steatosis does not cause insulin resistance in young mice because DAG accumulates in lipid droplets rather than the plasma membrane; in aged L-Mttp−/− mice, plasma membrane sn-1,2-DAG content increases with PKCε activation and hepatic insulin resistance, demonstrating that intracellular DAG compartmentalization determines insulin sensitivity independent of steatosis.","method":"Liver-specific Mttp KO mice; hyperinsulinemic-euglycemic clamps; subcellular DAG fractionation; PKCε activation assay; mitochondrial uncoupler treatment","journal":"Journal of lipid research","confidence":"High","confidence_rationale":"Tier 2 / Strong — conditional KO with clamp studies, subcellular fractionation, and pharmacological rescue providing mechanistic pathway placement","pmids":["32907986"],"is_preprint":false},{"year":2008,"finding":"The MTTP promoter polymorphism -164T>C mediates allele-specific promoter activity: the common -164T allele shows lower transcriptional activity than the rare -164C allele. EMSA revealed higher binding of transcription factor SREBP1a to the -164T probe, suggesting that SREBP1a binding to this site reduces MTTP promoter activity.","method":"Promoter-reporter (luciferase) assays in Huh-7 hepatoma cells; EMSA with SREBP1a","journal":"Human mutation","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — luciferase reporter with multiple haplotype constructs and EMSA, single lab","pmids":["17854051"],"is_preprint":false},{"year":2005,"finding":"Oleic acid directly stimulates MTP gene transcription in HepG2 cells through a region between -116 and -109 bp of the MTP promoter in an SRE-independent manner; palmitate, arachidonic acid, and linoleic acid do not stimulate MTP transcription.","method":"MTP promoter-luciferase reporter assays with deletion/mutation constructs in HepG2 cells; long-term oleic acid treatment with MTP mRNA quantification","journal":"Biochemistry","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — promoter deletion mapping and promoter mutagenesis with fatty acid specificity controls, single lab","pmids":["15723548"],"is_preprint":false},{"year":2011,"finding":"Hepatitis B virus (HBV) infection suppresses MTP mRNA and protein expression in a dose-dependent manner in transfected HepG2 cells, leading to decreased apoB expression and secretion.","method":"HBV infectious clone (pHBV1.3) transfection in HepG2 cells; RT-PCR and western blot for MTP and apoB","journal":"Lipids in health and disease","confidence":"Low","confidence_rationale":"Tier 3 / Weak — single lab, single transfection model, no mechanistic pathway identified beyond expression reduction","pmids":["22074108"],"is_preprint":false},{"year":2011,"finding":"Acute insulin suppression of apoB secretion occurs independently of MTP: insulin does not alter hepatic MTP mRNA levels or lipid transfer activity acutely (2h) in vivo, and overexpression of MTP does not abrogate insulin-mediated suppression of apoB secretion in primary rat hepatocytes.","method":"In vivo insulin injection in apobec-1−/− mice; adenoviral MTP overexpression in primary rat hepatocytes; MTP lipid transfer activity assays; apoB secretion measurement","journal":"Biochemical and biophysical research communications","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — in vivo and in vitro approaches with gain-of-function, establishes negative result (MTP-independent acute insulin effect) rigorously","pmids":["21316344"],"is_preprint":false},{"year":2012,"finding":"Missense mutations Y528H and R540C in MTTP cause abetalipoproteinemia by abolishing lipid-transfer activity while retaining normal binding to PDI and apoB; N649S partially reduces activity; G264R retains full activity but causes ABL via a frameshift, identifying the region containing residues 528-540 as critical for the lipid-transfer catalytic domain.","method":"Transient expression in COS-7 cells; MTP lipid-transfer activity assays; co-immunoprecipitation with PDI and apoB constructs","journal":"Biochimica et biophysica acta","confidence":"Medium","confidence_rationale":"Tier 1/2 / Moderate — in vitro activity assay with mutagenesis panel, single lab","pmids":["25108285"],"is_preprint":false},{"year":2012,"finding":"MTTP splicing mutations causing exon deletions (Δ6 and Δ10) produce truncated proteins that fail to bind PDI and lack triglyceride transfer activity, but still localize normally to the ER, demonstrating that PDI binding and lipid transfer activity are not required for ER retention of MTTP.","method":"Minigene splicing reporter assays; transfection in HepG2/HeLa cells; PDI co-immunoprecipitation; ER localization by immunofluorescence; triglyceride transfer activity assay on duodenal biopsies","journal":"Human mutation","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — functional assay on patient biopsies plus cell-based mechanistic studies with multiple readouts, single lab","pmids":["22236406"],"is_preprint":false},{"year":2015,"finding":"MTP associates with cytosolic lipid droplet surfaces in adipocytes and fatty liver hepatocytes, redistributing from the juxtanuclear ER region to lipid droplets during 3T3-L1 adipocyte differentiation; MTP co-localizes with but does not overlap with perilipin 2 on droplets; inhibition of MTP activity does not affect TG export via lipolysis or secretion from adipocytes.","method":"Immunofluorescence microscopy; subcellular fractionation; MTP inhibitor treatment; lipid droplet isolation; differentiation time-course in 3T3-L1 cells","journal":"PloS one","confidence":"Medium","confidence_rationale":"Tier 3 / Moderate — localization by microscopy and fractionation confirmed in adipocytes and human liver, negative functional result explicitly tested, single lab","pmids":["26267806"],"is_preprint":false},{"year":2010,"finding":"High-fat diet-induced NAFLD in rats is associated with elevated DNA methylation of the MTTP promoter (at specific CpG sites including -113 and -20), which negatively correlates with MTTP expression; berberine reverses this methylation and restores MTTP expression and hepatic TG export.","method":"Bisulfite sequencing of MTTP promoter CpG sites; MTTP mRNA quantification; hepatic TG secretion measurement in high-fat diet rats treated with berberine","journal":"Journal of lipid research","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — correlation of promoter methylation with expression plus interventional reversal experiment, single lab","pmids":["20567026"],"is_preprint":false},{"year":2021,"finding":"Lipid overload activates PKCδ via oxidative stress, which prevents HNF4α nuclear entry, reducing MTP transcription and impairing VLDL secretion in hepatocytes; PKCδ inhibitor (Go6983) or ROS scavenger (NAC) partially rescues MTP expression and VLDL secretion.","method":"In vivo high-fat diet in large yellow croaker; in vitro oleic acid treatment of hepatocytes; PKCδ inhibitor and NAC treatments; HNF4α nuclear localization assays; MTP expression and VLDL secretion measurements","journal":"Free radical biology & medicine","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — in vivo and in vitro model with pharmacological rescue, mechanistic pathway (oxidative stress-PKCδ-HNF4α-MTP) established, single lab","pmids":["34116177"],"is_preprint":false},{"year":2022,"finding":"Adipocyte-derived exosomal MTTP enters CRC cells and forms a complex with PRAP1 that inhibits ZEB1 expression and upregulates GPX4 and xCT, reducing polyunsaturated fatty acid ratios and lipid ROS levels to suppress ferroptosis and promote chemoresistance to oxaliplatin.","method":"Exosome isolation and characterization; co-IP of MTTP-PRAP1 complex; siRNA knockdown and MTTP inhibitor experiments; organoid models; obese mouse tumor implantation model; lipid ROS measurement","journal":"Advanced science","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — co-IP, organoid, and in vivo model, multiple pathway components tested, single lab","pmids":["35978266"],"is_preprint":false},{"year":2021,"finding":"Cadmium exposure increases MTTP protein stability by inhibiting both proteasomal and lysosomal protein degradation pathways; the lysosomal pathway is disrupted via ER Ca2+ release through IP3R, and this Ca2+-dependent lysosomal deacidification leads to MTTP accumulation and elevated TG secretion.","method":"siRNA knockdown of MTTP; co-treatment with proteasome inhibitor MG132 and lysosome inhibitor CQ; intracellular Ca2+ chelation (BAPTA/AM); IP3R inhibition (2-APB); SERCA activation (CDN1163); TG and MTTP protein measurement in HepG2 cells","journal":"Chemico-biological interactions","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — pharmacological pathway dissection with multiple orthogonal inhibitors, single lab","pmids":["34516972"],"is_preprint":false}],"current_model":"MTTP (microsomal triglyceride transfer protein) is an ER-resident lipid transfer protein that forms a heterodimer with PDI and is essential for lipidating nascent apoB during VLDL and chylomicron assembly; it possesses functionally distinct apoB-binding (chaperone) and lipid-transfer catalytic domains, transfers neutral lipids and phospholipids (including phosphatidylethanolamine to CD1d for NKT cell development), associates with stable MTP-lipid complexes in the ER lumen that enhance apoB affinity, is transcriptionally regulated by HNF4α/HNF1α (activated), SHP/CLOCK (circadian repression), FoxO6 (insulin-sensitive activation), NR2F1/NCoR1 (repression), and SREBP1a (allele-specific), is post-transcriptionally regulated by IRE1β-mediated mRNA degradation in enterocytes and by IRE1α-XBP1s-PDI activity in hepatocytes, and can localize to cytosolic lipid droplet surfaces in adipocytes and steatotic hepatocytes."},"narrative":{"mechanistic_narrative":"MTTP (microsomal triglyceride transfer protein) is an endoplasmic reticulum lipid-transfer protein that is essential and rate-limiting for the assembly and secretion of apolipoprotein B-containing lipoproteins, including hepatic VLDL and intestinal chylomicrons [PMID:9784135, PMID:10553017, PMID:16354657]. It carries two functionally separable activities: an apoB-binding (chaperone) domain that physically engages nascent apoB, and an independent lipid-transfer catalytic domain, since a selective inhibitor of apoB-MTP binding blocks apoB secretion without affecting lipid transfer [PMID:10769147], and abetalipoproteinemia-causing mutations (Y528H, R540C) abolish lipid-transfer activity while retaining normal binding to PDI and apoB [PMID:25108285]. MTP binds phospholipid vesicles to form stable ER-luminal MTP-lipid complexes, with zwitterionic phospholipids increasing apoB100 affinity 2-4 fold and negatively charged lipids reducing it [PMID:11427523], and it forms a ternary complex with the TG-binding protein PRAP1 that is required for efficient apoB-lipoprotein assembly [PMID:33168624]. Tissue-specific loss-of-function studies establish a cell-autonomous requirement: intestinal deletion abolishes chylomicron assembly and causes enterocyte lipid accumulation [PMID:16354657], and patient-derived MTTP-mutant hepatocytes and cardiomyocytes fail to secrete apoB and accumulate lipid, phenotypes rescued by CRISPR correction [PMID:28514664]. Beyond bulk neutral-lipid transfer, an alternately promoted splice variant (MTPv1) transfers phosphatidylethanolamine to CD1d and is required for NKT cell development [PMID:17312007]. MTP expression is tightly controlled transcriptionally by HNF4α/HNF1α activation opposed by NR2F1/NCoR1 repression [PMID:22357705], by CLOCK→SHP circadian repression [PMID:20674862], and by insulin-sensitive FoxO6 activation [PMID:24437489], and post-transcriptionally by IRE1β-mediated mRNA degradation in enterocytes [PMID:18460335] and the IRE1α-XBP1s-PDI axis in hepatocytes [PMID:23040069]. Loss of MTTP-dependent lipid export drives intracellular lipid retention whose subcellular compartmentalization, rather than steatosis per se, dictates hepatic insulin sensitivity [PMID:32907986].","teleology":[{"year":1998,"claim":"Established that MTP is required for production of apoB-containing lipoproteins, validating it as the assembly machinery and a pharmacological lipid-lowering target.","evidence":"Small-molecule MTP inhibitors in rodents and WHHL rabbits, with in vitro MTP assay","pmids":["9784135"],"confidence":"High","gaps":["Did not resolve which MTP activity (lipid transfer vs apoB binding) the inhibitors blocked","Did not establish whether MTP is rate-limiting under basal conditions"]},{"year":1999,"claim":"Showed MTP is rate-limiting for VLDL apoB secretion, not merely permissive, by demonstrating that raising MTP increases lipoprotein output.","evidence":"Adenoviral hepatic MTP overexpression in mice with in vivo secretion-rate measurement","pmids":["10553017"],"confidence":"High","gaps":["Did not address intestinal/chylomicron pathway","Mechanism of rate limitation at the molecular step not dissected"]},{"year":2000,"claim":"Resolved MTP into two functionally independent domains by showing apoB binding can be inhibited separately from lipid transfer.","evidence":"Competitive binding, co-IP, and a selective apoB-MTP binding inhibitor in HepG2 cells","pmids":["10769147"],"confidence":"High","gaps":["Residue-level mapping of the two domains not defined here","Relative contribution of each domain in vivo unquantified"]},{"year":2001,"claim":"Explained how lipid context modulates MTP function by showing MTP forms ER-luminal MTP-lipid complexes whose phospholipid charge tunes apoB affinity.","evidence":"In vitro lipid-binding/interaction assays and microsomal fractionation across COS, HepG2, and mouse liver","pmids":["11427523"],"confidence":"High","gaps":["Structural basis of charge-dependent affinity change unknown","In vivo relevance of complex stoichiometry not established"]},{"year":2005,"claim":"Demonstrated the cell-autonomous, tissue-specific requirement for MTTP in intestinal chylomicron assembly and revealed hepatic compensation.","evidence":"Inducible intestine-specific Mttp knockout with EM and in vivo/in vitro secretion assays","pmids":["16354657"],"confidence":"High","gaps":["Mechanism of compensatory hepatic lipogenesis not defined"]},{"year":2007,"claim":"Extended MTP function beyond bulk lipoprotein assembly to immune lipid antigen presentation, showing a splice variant transfers PE to CD1d for NKT development.","evidence":"Identification of MTPv1, in vitro PE transfer to CD1d, and MTP antagonist loss-of-function in fetal thymic organ culture","pmids":["17312007"],"confidence":"High","gaps":["In vivo NKT requirement via genetic MTPv1 deletion not shown","Structural basis of CD1d lipid loading by MTP unresolved"]},{"year":2008,"claim":"Defined post-transcriptional control of MTP, showing IRE1β selectively degrades MTP mRNA in enterocytes to limit chylomicron output.","evidence":"Ire1b-/- mice with diet challenge, primary enterocytes, and siRNA knockdown","pmids":["18460335"],"confidence":"High","gaps":["Cleavage specificity determinants on MTP mRNA not mapped","Tissue restriction mechanism (intestine vs liver) unexplained"]},{"year":2008,"claim":"Linked a common MTTP promoter polymorphism to allele-specific transcription via differential SREBP1a binding.","evidence":"Promoter-reporter assays and EMSA in Huh-7 cells","pmids":["17854051"],"confidence":"Medium","gaps":["In vivo physiological impact of the -164T>C allele not established","Whether SREBP1a binding is causally repressive untested in vivo"]},{"year":2010,"claim":"Connected the circadian clock to lipoprotein rhythms by defining a CLOCK→SHP→MTP transcriptional repression axis.","evidence":"Clock-mutant and Shp-/- mice, promoter binding, knockdown, and SHP rescue of hypertriglyceridemia","pmids":["20674862"],"confidence":"High","gaps":["Quantitative contribution of this axis to total diurnal MTP variation unclear"]},{"year":2010,"claim":"Implicated epigenetic silencing of MTTP in diet-induced NAFLD and showed it is pharmacologically reversible.","evidence":"Bisulfite sequencing and berberine intervention in high-fat-diet rats","pmids":["20567026"],"confidence":"Medium","gaps":["Methyltransferase/demethylase responsible not identified","Causality of methylation vs expression not separated from confounders"]},{"year":2012,"claim":"Defined NR2F1/NCoR1 as a corepressor module antagonizing HNF4α/HNF1α synergy at the MTTP promoter.","evidence":"Promoter-reporter, EMSA, and TF co-transfection in intestinal cells","pmids":["22357705"],"confidence":"Medium","gaps":["In vivo confirmation of NR2F1 repression lacking","Physiological signals controlling NR2F1 occupancy unknown"]},{"year":2012,"claim":"Defined the IRE1α-XBP1s-PDI arm as a hepatic regulator of MTP activity controlling ER lipid partitioning into VLDL.","evidence":"Hepatocyte-specific Ire1α knockout with MTP activity, lipogenesis, apoB, and PDI readouts","pmids":["23040069"],"confidence":"High","gaps":["Whether PDI level is the sole limiting factor for MTP activity not isolated"]},{"year":2012,"claim":"Mapped the lipid-transfer catalytic region by showing ABL mutations Y528H/R540C abolish transfer while preserving PDI and apoB binding.","evidence":"Transient expression in COS-7 with lipid-transfer assays and co-IP of mutant panel","pmids":["25108285"],"confidence":"Medium","gaps":["No high-resolution structure of the catalytic domain provided","Single-lab activity assay without orthogonal confirmation"]},{"year":2012,"claim":"Separated ER retention from function, showing PDI binding and lipid transfer are dispensable for MTTP ER localization.","evidence":"Minigene splicing reporters, PDI co-IP, immunofluorescence, and biopsy transfer assays","pmids":["22236406"],"confidence":"Medium","gaps":["ER retention signal/determinant not identified","Single-lab study"]},{"year":2014,"claim":"Placed MTP under insulin-sensitive transcriptional control via FoxO6, linking insulin resistance to hypertriglyceridemia.","evidence":"Transgenic/knockdown and db/db mouse models, promoter mutagenesis, and primary human hepatocytes","pmids":["24437489"],"confidence":"High","gaps":["Interplay between FoxO6 and other MTP regulators not integrated"]},{"year":2015,"claim":"Identified a SAP18/TRIB1/mSin3A regulatory module occupying MTTP regulatory sequences to set hepatic expression and plasma lipids.","evidence":"Yeast two-hybrid, adenoviral gain/loss in mouse liver, and ChIP","pmids":["25921304"],"confidence":"Medium","gaps":["Direct vs indirect regulation of MTTP by this complex not fully resolved","Single-lab study"]},{"year":2015,"claim":"Revealed a non-ER, lipid-droplet-associated localization of MTP in adipocytes and steatotic hepatocytes, though without a defined droplet-export function.","evidence":"Immunofluorescence, fractionation, and MTP inhibitor treatment across 3T3-L1 and human liver","pmids":["26267806"],"confidence":"Medium","gaps":["Functional role of droplet-localized MTP unknown","Mechanism of ER-to-droplet redistribution undefined"]},{"year":2017,"claim":"Provided isogenic genetic proof of cell-autonomous MTTP requirement in human hepatocytes and cardiomyocytes via CRISPR rescue.","evidence":"Patient MTTPR46G iPSC-derived cells with CRISPR correction and apoB/lipid/death readouts","pmids":["28514664"],"confidence":"High","gaps":["Why cardiomyocytes are particularly vulnerable to lipid accumulation not mechanistically resolved"]},{"year":2020,"claim":"Identified PRAP1 as a TG-binding cofactor forming a ternary complex with MTTP required for efficient apoB-lipoprotein assembly and dietary lipid absorption.","evidence":"In vitro ternary complex reconstitution, E85V mutagenesis, and PRAP1-KO/knock-in mice on high-fat diet","pmids":["33168624"],"confidence":"High","gaps":["Stoichiometry and structural arrangement of the MTTP-PRAP1-TG complex unresolved"]},{"year":2020,"claim":"Dissociated steatosis from insulin resistance by showing MTTP-loss-driven DAG compartmentalization, not lipid mass, determines hepatic insulin sensitivity.","evidence":"Liver-specific Mttp KO mice with clamps, subcellular DAG fractionation, and PKCε assays","pmids":["32907986"],"confidence":"High","gaps":["Determinants of DAG partitioning between droplets and plasma membrane not defined"]},{"year":2021,"claim":"Connected lipid-overload oxidative stress to MTP suppression through a PKCδ-HNF4α axis blocking HNF4α nuclear entry.","evidence":"In vivo croaker and in vitro hepatocyte models with PKCδ inhibitor and NAC rescue","pmids":["34116177"],"confidence":"Medium","gaps":["Mammalian confirmation limited","Direct PKCδ-HNF4α phosphorylation event not demonstrated"]},{"year":2021,"claim":"Showed environmental cadmium raises MTTP protein stability via IP3R-Ca2+-dependent lysosomal deacidification and proteasomal inhibition, elevating TG secretion.","evidence":"Pharmacological dissection (MG132, CQ, BAPTA, 2-APB, CDN1163) with MTTP/TG readouts in HepG2","pmids":["34516972"],"confidence":"Medium","gaps":["E3 ligase/degradation machinery for MTTP not identified","Single-lab study"]},{"year":2022,"claim":"Revealed a non-canonical extracellular role: adipocyte exosomal MTTP-PRAP1 complexes suppress ferroptosis to drive colorectal cancer chemoresistance.","evidence":"Exosome isolation, MTTP-PRAP1 co-IP, knockdown/inhibitor, organoids, and obese-mouse tumor model","pmids":["35978266"],"confidence":"Medium","gaps":["Mechanism of MTTP secretion into exosomes unclear","Link from MTTP-PRAP1 to ZEB1/GPX4/xCT not fully mechanistic"]},{"year":null,"claim":"How MTTP's catalytic and chaperone domains are structurally arranged and coordinate with PRAP1 and ER-luminal lipid complexes during lipoprotein assembly remains unresolved.","evidence":"","pmids":[],"confidence":"Medium","gaps":["No high-resolution structure of MTTP in the timeline","Stoichiometry of MTTP-lipid and MTTP-PRAP1-TG complexes undefined","Mechanism of ER-to-lipid-droplet and exosomal redistribution unknown"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0008289","term_label":"lipid binding","supporting_discovery_ids":[3,5,13,19]},{"term_id":"GO:0140104","term_label":"molecular carrier activity","supporting_discovery_ids":[3,5,13]},{"term_id":"GO:0044183","term_label":"protein folding chaperone","supporting_discovery_ids":[2]}],"localization":[{"term_id":"GO:0005783","term_label":"endoplasmic reticulum","supporting_discovery_ids":[3,13,20]},{"term_id":"GO:0005811","term_label":"lipid droplet","supporting_discovery_ids":[21]}],"pathway":[{"term_id":"R-HSA-1430728","term_label":"Metabolism","supporting_discovery_ids":[0,1,4]},{"term_id":"R-HSA-8963743","term_label":"Digestion and absorption","supporting_discovery_ids":[4,13]},{"term_id":"R-HSA-74160","term_label":"Gene expression (Transcription)","supporting_discovery_ids":[7,9,10]}],"complexes":["MTP-PDI heterodimer","MTTP-PRAP1-TG ternary complex"],"partners":["APOB","PDI","PRAP1","CD1D"],"other_free_text":[]}},"prefetch_data":{"uniprot":{"accession":"P55157","full_name":"Microsomal triglyceride transfer protein large subunit","aliases":[],"length_aa":894,"mass_kda":99.4,"function":"Catalyzes the transport of triglyceride, cholesteryl ester, and phospholipid between phospholipid surfaces (PubMed:15897609, PubMed:16478722, PubMed:22236406, PubMed:23475612, PubMed:25108285, PubMed:26224785, PubMed:8876250, PubMed:8939939). Required for the assembly and secretion of plasma lipoproteins that contain apolipoprotein B (PubMed:16478722, PubMed:23475612, PubMed:26224785, PubMed:8876250, PubMed:8939939). May be involved in regulating cholesteryl ester biosynthesis in cells that produce lipoproteins (By similarity)","subcellular_location":"Endoplasmic reticulum; Golgi apparatus","url":"https://www.uniprot.org/uniprotkb/P55157/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/MTTP","classification":"Not Classified","n_dependent_lines":0,"n_total_lines":1208,"dependency_fraction":0.0},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/MTTP","total_profiled":1310},"omim":[{"mim_id":"610726","title":"TRUB PSEUDOURIDINE SYNTHASE FAMILY MEMBER 1; TRUB1","url":"https://www.omim.org/entry/610726"},{"mim_id":"590075","title":"TRANSFER RNA, MITOCHONDRIAL, PROLINE; MTTP","url":"https://www.omim.org/entry/590075"},{"mim_id":"545000","title":"MYOCLONIC EPILEPSY ASSOCIATED WITH RAGGED-RED FIBERS; MERRF","url":"https://www.omim.org/entry/545000"},{"mim_id":"200100","title":"ABETALIPOPROTEINEMIA; ABL","url":"https://www.omim.org/entry/200100"},{"mim_id":"157147","title":"MICROSOMAL TRIGLYCERIDE TRANSFER PROTEIN; MTTP","url":"https://www.omim.org/entry/157147"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Approved","locations":[{"location":"Endoplasmic reticulum","reliability":"Approved"},{"location":"Cytosol","reliability":"Approved"}],"tissue_specificity":"Group enriched","tissue_distribution":"Detected in some","driving_tissues":[{"tissue":"intestine","ntpm":259.2},{"tissue":"liver","ntpm":249.2}],"url":"https://www.proteinatlas.org/search/MTTP"},"hgnc":{"alias_symbol":["ABL"],"prev_symbol":["MTP"]},"alphafold":{"accession":"P55157","domains":[{"cath_id":"-","chopping":"302-365","consensus_level":"medium","plddt":92.017,"start":302,"end":365},{"cath_id":"2.20.50.20","chopping":"614-720","consensus_level":"medium","plddt":82.9306,"start":614,"end":720},{"cath_id":"1.20.58","chopping":"380-481","consensus_level":"medium","plddt":93.7876,"start":380,"end":481}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/P55157","model_url":"https://alphafold.ebi.ac.uk/files/AF-P55157-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-P55157-F1-predicted_aligned_error_v6.png","plddt_mean":86.56},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=MTTP","jax_strain_url":"https://www.jax.org/strain/search?query=MTTP"},"sequence":{"accession":"P55157","fasta_url":"https://rest.uniprot.org/uniprotkb/P55157.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/P55157/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/P55157"}},"corpus_meta":[{"pmid":"9784135","id":"PMC_9784135","title":"An MTP inhibitor that normalizes atherogenic lipoprotein levels in WHHL rabbits.","date":"1998","source":"Science (New York, N.Y.)","url":"https://pubmed.ncbi.nlm.nih.gov/9784135","citation_count":226,"is_preprint":false},{"pmid":"35978266","id":"PMC_35978266","title":"Adipocyte-Derived Exosomal MTTP Suppresses Ferroptosis and Promotes Chemoresistance in Colorectal Cancer.","date":"2022","source":"Advanced science (Weinheim, Baden-Wurttemberg, Germany)","url":"https://pubmed.ncbi.nlm.nih.gov/35978266","citation_count":207,"is_preprint":false},{"pmid":"23040069","id":"PMC_23040069","title":"IRE1α-XBP1s induces PDI expression to increase MTP activity for hepatic VLDL assembly and lipid homeostasis.","date":"2012","source":"Cell metabolism","url":"https://pubmed.ncbi.nlm.nih.gov/23040069","citation_count":189,"is_preprint":false},{"pmid":"12837854","id":"PMC_12837854","title":"CP-346086: an MTP inhibitor that lowers plasma cholesterol and triglycerides in experimental animals and in humans.","date":"2003","source":"Journal of lipid research","url":"https://pubmed.ncbi.nlm.nih.gov/12837854","citation_count":157,"is_preprint":false},{"pmid":"11352979","id":"PMC_11352979","title":"Secretion of hepatocyte apoB is inhibited by the flavonoids, naringenin and hesperetin, via reduced activity and expression of ACAT2 and MTP.","date":"2001","source":"Journal of lipid research","url":"https://pubmed.ncbi.nlm.nih.gov/11352979","citation_count":149,"is_preprint":false},{"pmid":"20674862","id":"PMC_20674862","title":"Diurnal regulation of MTP and plasma triglyceride by CLOCK is mediated by SHP.","date":"2010","source":"Cell metabolism","url":"https://pubmed.ncbi.nlm.nih.gov/20674862","citation_count":146,"is_preprint":false},{"pmid":"10553017","id":"PMC_10553017","title":"Hepatic overexpression of microsomal triglyceride transfer protein (MTP) results in increased in vivo secretion of VLDL triglycerides and apolipoprotein B.","date":"1999","source":"Journal of lipid research","url":"https://pubmed.ncbi.nlm.nih.gov/10553017","citation_count":123,"is_preprint":false},{"pmid":"20567026","id":"PMC_20567026","title":"Berberine reduces methylation of the MTTP promoter and alleviates fatty liver induced by a high-fat diet in rats.","date":"2010","source":"Journal of lipid research","url":"https://pubmed.ncbi.nlm.nih.gov/20567026","citation_count":122,"is_preprint":false},{"pmid":"18460335","id":"PMC_18460335","title":"IRE1beta inhibits chylomicron production by selectively degrading MTP mRNA.","date":"2008","source":"Cell metabolism","url":"https://pubmed.ncbi.nlm.nih.gov/18460335","citation_count":108,"is_preprint":false},{"pmid":"24456734","id":"PMC_24456734","title":"Betaine attenuates hepatic steatosis by reducing methylation of the MTTP promoter and elevating genomic methylation in mice fed a high-fat diet.","date":"2013","source":"The Journal of nutritional biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/24456734","citation_count":106,"is_preprint":false},{"pmid":"16354657","id":"PMC_16354657","title":"Compensatory increase in hepatic lipogenesis in mice with conditional intestine-specific Mttp deficiency.","date":"2005","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/16354657","citation_count":102,"is_preprint":false},{"pmid":"16428741","id":"PMC_16428741","title":"Ancylostoma caninum MTP-1, an astacin-like metalloprotease secreted by infective hookworm larvae, is involved in tissue migration.","date":"2006","source":"Infection and immunity","url":"https://pubmed.ncbi.nlm.nih.gov/16428741","citation_count":93,"is_preprint":false},{"pmid":"21236304","id":"PMC_21236304","title":"Viral genotype-specific role of PNPLA3, PPARG, MTTP, and IL28B in hepatitis C virus-associated steatosis.","date":"2011","source":"Journal of hepatology","url":"https://pubmed.ncbi.nlm.nih.gov/21236304","citation_count":86,"is_preprint":false},{"pmid":"15911777","id":"PMC_15911777","title":"No association between microsomal triglyceride transfer protein (MTP) haplotype and longevity in humans.","date":"2005","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/15911777","citation_count":83,"is_preprint":false},{"pmid":"15837211","id":"PMC_15837211","title":"Effect of combining the larval antigens Ancylostoma secreted protein 2 (ASP-2) and metalloprotease 1 (MTP-1) in protecting hamsters against hookworm infection and disease caused by Ancylostoma ceylanicum.","date":"2005","source":"Vaccine","url":"https://pubmed.ncbi.nlm.nih.gov/15837211","citation_count":67,"is_preprint":false},{"pmid":"9514536","id":"PMC_9514536","title":"Membrane-type matrix metalloproteinase-1(MT1-MTP) gene is overexpressed in highly invasive hepatocellular carcinomas.","date":"1998","source":"Journal of hepatology","url":"https://pubmed.ncbi.nlm.nih.gov/9514536","citation_count":65,"is_preprint":false},{"pmid":"16188040","id":"PMC_16188040","title":"JTT-130, a microsomal triglyceride transfer protein (MTP) inhibitor lowers plasma triglycerides and LDL cholesterol concentrations without increasing hepatic triglycerides in guinea pigs.","date":"2005","source":"BMC cardiovascular disorders","url":"https://pubmed.ncbi.nlm.nih.gov/16188040","citation_count":62,"is_preprint":false},{"pmid":"17312007","id":"PMC_17312007","title":"MTP regulated by an alternate promoter is essential for NKT cell development.","date":"2007","source":"The Journal of experimental medicine","url":"https://pubmed.ncbi.nlm.nih.gov/17312007","citation_count":55,"is_preprint":false},{"pmid":"17227233","id":"PMC_17227233","title":"MTP inhibition as a treatment for dyslipidaemias: time to deliver or empty promises?","date":"2007","source":"Expert opinion on therapeutic targets","url":"https://pubmed.ncbi.nlm.nih.gov/17227233","citation_count":53,"is_preprint":false},{"pmid":"10769147","id":"PMC_10769147","title":"Decreased secretion of ApoB follows inhibition of ApoB-MTP binding by a novel antagonist.","date":"2000","source":"Biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/10769147","citation_count":53,"is_preprint":false},{"pmid":"8744579","id":"PMC_8744579","title":"Safety and immunogenicity of Env 2-3, a human immunodeficiency virus type 1 candidate vaccine, in combination with a novel adjuvant, MTP-PE/MF59. NIAID AIDS Vaccine Evaluation Group.","date":"1996","source":"AIDS research and human retroviruses","url":"https://pubmed.ncbi.nlm.nih.gov/8744579","citation_count":53,"is_preprint":false},{"pmid":"24924182","id":"PMC_24924182","title":"Muramyl tripeptide-phosphatidyl ethanolamine encapsulated in liposomes (L-MTP-PE) in the treatment of osteosarcoma.","date":"2014","source":"Advances in experimental medicine and biology","url":"https://pubmed.ncbi.nlm.nih.gov/24924182","citation_count":52,"is_preprint":false},{"pmid":"8280710","id":"PMC_8280710","title":"Liposome-encapsulated MTP-PE: a novel biologic agent for cancer therapy.","date":"1993","source":"Journal of immunotherapy with emphasis on tumor immunology : official journal of the Society for Biological Therapy","url":"https://pubmed.ncbi.nlm.nih.gov/8280710","citation_count":51,"is_preprint":false},{"pmid":"32277051","id":"PMC_32277051","title":"Restoring mitochondrial superoxide levels with elamipretide (MTP-131) protects db/db mice against progression of diabetic kidney disease.","date":"2020","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/32277051","citation_count":50,"is_preprint":false},{"pmid":"23332773","id":"PMC_23332773","title":"Rapid regression of atherosclerosis with MTP inhibitor treatment.","date":"2013","source":"Atherosclerosis","url":"https://pubmed.ncbi.nlm.nih.gov/23332773","citation_count":48,"is_preprint":false},{"pmid":"15910857","id":"PMC_15910857","title":"Mutations in MTP gene in abeta- and hypobeta-lipoproteinemia.","date":"2005","source":"Atherosclerosis","url":"https://pubmed.ncbi.nlm.nih.gov/15910857","citation_count":47,"is_preprint":false},{"pmid":"35037731","id":"PMC_35037731","title":"Tunable Microgel-Templated Porogel (MTP) Bioink for 3D Bioprinting Applications.","date":"2022","source":"Advanced healthcare materials","url":"https://pubmed.ncbi.nlm.nih.gov/35037731","citation_count":44,"is_preprint":false},{"pmid":"15380446","id":"PMC_15380446","title":"Inhibitory activity of diacylglycerol acyltransferase (DGAT) and microsomal triglyceride transfer protein (MTP) by the flavonoid, taxifolin, in HepG2 cells: potential role in the regulation of apolipoprotein B secretion.","date":"2004","source":"Atherosclerosis","url":"https://pubmed.ncbi.nlm.nih.gov/15380446","citation_count":43,"is_preprint":false},{"pmid":"20510883","id":"PMC_20510883","title":"Mechanisms underlying different responses of plasma triglyceride to high-fat diets in hamsters and mice: roles of hepatic MTP and triglyceride secretion.","date":"2010","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/20510883","citation_count":43,"is_preprint":false},{"pmid":"31741187","id":"PMC_31741187","title":"Lomitapide and Mipomersen-Inhibiting Microsomal Triglyceride Transfer Protein (MTP) and apoB100 Synthesis.","date":"2019","source":"Current atherosclerosis reports","url":"https://pubmed.ncbi.nlm.nih.gov/31741187","citation_count":40,"is_preprint":false},{"pmid":"15466039","id":"PMC_15466039","title":"Thermophilic, reversible gamma-resorcylate decarboxylase from Rhizobium sp. strain MTP-10005: purification, molecular characterization, and expression.","date":"2004","source":"Journal of bacteriology","url":"https://pubmed.ncbi.nlm.nih.gov/15466039","citation_count":39,"is_preprint":false},{"pmid":"23738963","id":"PMC_23738963","title":"MTTP polymorphisms and susceptibility to non-alcoholic fatty liver disease in a Han Chinese population.","date":"2013","source":"Liver international : official journal of the International Association for the Study of the Liver","url":"https://pubmed.ncbi.nlm.nih.gov/23738963","citation_count":37,"is_preprint":false},{"pmid":"15857311","id":"PMC_15857311","title":"Current biology of MTP: implications for selective inhibition.","date":"2005","source":"Current topics in medicinal chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/15857311","citation_count":36,"is_preprint":false},{"pmid":"34866994","id":"PMC_34866994","title":"Comprehensive genome wide identification and expression analysis of MTP gene family in tomato (Solanum lycopersicum) under multiple heavy metal stress.","date":"2021","source":"Saudi journal of biological sciences","url":"https://pubmed.ncbi.nlm.nih.gov/34866994","citation_count":36,"is_preprint":false},{"pmid":"18482281","id":"PMC_18482281","title":"Microsomal triglyceride transfer protein (MTP) -493G/T gene polymorphism contributes to fat liver accumulation in HCV genotype 3 infected patients.","date":"2008","source":"Journal of viral hepatitis","url":"https://pubmed.ncbi.nlm.nih.gov/18482281","citation_count":36,"is_preprint":false},{"pmid":"14684575","id":"PMC_14684575","title":"Ferroportin/IREG-1/MTP-1/SLC40A1 modulates the uptake of iron at the apical membrane of enterocytes.","date":"2004","source":"Gut","url":"https://pubmed.ncbi.nlm.nih.gov/14684575","citation_count":36,"is_preprint":false},{"pmid":"25030663","id":"PMC_25030663","title":"Intestine-specific MTP and global ACAT2 deficiency lowers acute cholesterol absorption with chylomicrons and HDLs.","date":"2014","source":"Journal of lipid research","url":"https://pubmed.ncbi.nlm.nih.gov/25030663","citation_count":35,"is_preprint":false},{"pmid":"33168624","id":"PMC_33168624","title":"PRAP1 is a novel lipid-binding protein that promotes lipid absorption by facilitating MTTP-mediated lipid transport.","date":"2020","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/33168624","citation_count":35,"is_preprint":false},{"pmid":"10679949","id":"PMC_10679949","title":"Microsomal triglyceride transfer protein (MTP) gene mutations in Canadian subjects with abetalipoproteinemia.","date":"2000","source":"Human mutation","url":"https://pubmed.ncbi.nlm.nih.gov/10679949","citation_count":35,"is_preprint":false},{"pmid":"20381565","id":"PMC_20381565","title":"Long-chain 3-hydroxy fatty acids accumulating in LCHAD and MTP deficiencies induce oxidative stress in rat brain.","date":"2010","source":"Neurochemistry international","url":"https://pubmed.ncbi.nlm.nih.gov/20381565","citation_count":35,"is_preprint":false},{"pmid":"28514664","id":"PMC_28514664","title":"Lack of MTTP Activity in Pluripotent Stem Cell-Derived Hepatocytes and Cardiomyocytes Abolishes apoB Secretion and Increases Cell Stress.","date":"2017","source":"Cell reports","url":"https://pubmed.ncbi.nlm.nih.gov/28514664","citation_count":34,"is_preprint":false},{"pmid":"22236406","id":"PMC_22236406","title":"Molecular and functional analysis of two new MTTP gene mutations in an atypical case of abetalipoproteinemia.","date":"2012","source":"Journal of lipid research","url":"https://pubmed.ncbi.nlm.nih.gov/22236406","citation_count":33,"is_preprint":false},{"pmid":"24437489","id":"PMC_24437489","title":"FoxO6 integrates insulin signaling with MTP for regulating VLDL production in the liver.","date":"2014","source":"Endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/24437489","citation_count":33,"is_preprint":false},{"pmid":"21697135","id":"PMC_21697135","title":"Mitochondria-targeted peptide MTP-131 alleviates mitochondrial dysfunction and oxidative damage in human trabecular meshwork cells.","date":"2011","source":"Investigative ophthalmology & visual science","url":"https://pubmed.ncbi.nlm.nih.gov/21697135","citation_count":33,"is_preprint":false},{"pmid":"8021814","id":"PMC_8021814","title":"Effect of MTP-PE liposomes and interleukin-7 on induction of antibody and cell-mediated immune responses to a recombinant HIV-envelope protein.","date":"1994","source":"Journal of acquired immune deficiency syndromes","url":"https://pubmed.ncbi.nlm.nih.gov/8021814","citation_count":32,"is_preprint":false},{"pmid":"22342726","id":"PMC_22342726","title":"Impaired fatty acid oxidation in a Drosophila model of mitochondrial trifunctional protein (MTP) deficiency.","date":"2012","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/22342726","citation_count":32,"is_preprint":false},{"pmid":"19733470","id":"PMC_19733470","title":"Lipoprotein metabolism mediates the association of MTP polymorphism with beta-cell dysfunction in healthy subjects and in nondiabetic normolipidemic patients with nonalcoholic steatohepatitis.","date":"2009","source":"The Journal of nutritional biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/19733470","citation_count":32,"is_preprint":false},{"pmid":"31136613","id":"PMC_31136613","title":"Molecular characterization and expression dynamics of MTP genes under various spatio-temporal stages and metal stress conditions in rice.","date":"2019","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/31136613","citation_count":31,"is_preprint":false},{"pmid":"26458397","id":"PMC_26458397","title":"MTTP-297H polymorphism reduced serum cholesterol but increased risk of non-alcoholic fatty liver disease-a cross-sectional study.","date":"2015","source":"BMC medical genetics","url":"https://pubmed.ncbi.nlm.nih.gov/26458397","citation_count":31,"is_preprint":false},{"pmid":"26748229","id":"PMC_26748229","title":"Evaluation of the role of Mycobacterium tuberculosis pili (MTP) as an adhesin, invasin, and cytokine inducer of epithelial cells.","date":"2015","source":"The Brazilian journal of infectious diseases : an official publication of the Brazilian Society of Infectious Diseases","url":"https://pubmed.ncbi.nlm.nih.gov/26748229","citation_count":31,"is_preprint":false},{"pmid":"2460255","id":"PMC_2460255","title":"Modulation of interferon-gamma-induced major histocompatibility (MHC) and CD14 antigen changes by lipophilic muramyltripeptide MTP-PE in human monocytes.","date":"1988","source":"Cellular immunology","url":"https://pubmed.ncbi.nlm.nih.gov/2460255","citation_count":31,"is_preprint":false},{"pmid":"34504563","id":"PMC_34504563","title":"Berberine ameliorates nonalcoholic fatty liver disease by decreasing the liver lipid content via reversing the abnormal expression of MTTP and LDLR.","date":"2021","source":"Experimental and therapeutic medicine","url":"https://pubmed.ncbi.nlm.nih.gov/34504563","citation_count":30,"is_preprint":false},{"pmid":"23376445","id":"PMC_23376445","title":"Molecular cloning and characterisation of in vitro immune response against astacin-like metalloprotease Ace-MTP-2 from Ancylostoma ceylanicum.","date":"2013","source":"Experimental parasitology","url":"https://pubmed.ncbi.nlm.nih.gov/23376445","citation_count":30,"is_preprint":false},{"pmid":"22357705","id":"PMC_22357705","title":"NR2F1 disrupts synergistic activation of the MTTP gene transcription by HNF-4α and HNF-1α.","date":"2012","source":"Journal of lipid research","url":"https://pubmed.ncbi.nlm.nih.gov/22357705","citation_count":28,"is_preprint":false},{"pmid":"12197314","id":"PMC_12197314","title":"Microsomal triglyceride transfer protein (MTP) inhibitors: discovery of clinically active inhibitors using high-throughput screening and parallel synthesis paradigms.","date":"2002","source":"Current opinion in drug discovery & development","url":"https://pubmed.ncbi.nlm.nih.gov/12197314","citation_count":28,"is_preprint":false},{"pmid":"33744096","id":"PMC_33744096","title":"MTP deficiency caused by HADHB mutations: Pathophysiology and clinical manifestations.","date":"2021","source":"Molecular genetics and metabolism","url":"https://pubmed.ncbi.nlm.nih.gov/33744096","citation_count":27,"is_preprint":false},{"pmid":"24987866","id":"PMC_24987866","title":"Microsomal transfer protein (MTP) inhibition-a novel approach to the treatment of homozygous hypercholesterolemia.","date":"2014","source":"Annals of medicine","url":"https://pubmed.ncbi.nlm.nih.gov/24987866","citation_count":26,"is_preprint":false},{"pmid":"31065499","id":"PMC_31065499","title":"Genome-wide identification and characterization of the metal tolerance protein (MTP) family in grape (Vitis vinifera L.).","date":"2019","source":"3 Biotech","url":"https://pubmed.ncbi.nlm.nih.gov/31065499","citation_count":26,"is_preprint":false},{"pmid":"24721207","id":"PMC_24721207","title":"Mycobacterium tuberculosis pili (MTP), a putative biomarker for a tuberculosis diagnostic test.","date":"2014","source":"Tuberculosis (Edinburgh, Scotland)","url":"https://pubmed.ncbi.nlm.nih.gov/24721207","citation_count":26,"is_preprint":false},{"pmid":"9831631","id":"PMC_9831631","title":"Identification of two polymorphisms in the promoter of the microsomal triglyceride transfer protein (MTP) gene: lack of association with lipoprotein profiles.","date":"1998","source":"Journal of lipid research","url":"https://pubmed.ncbi.nlm.nih.gov/9831631","citation_count":26,"is_preprint":false},{"pmid":"34116177","id":"PMC_34116177","title":"Lipid overload impairs hepatic VLDL secretion via oxidative stress-mediated PKCδ-HNF4α-MTP pathway in large yellow croaker (Larimichthys crocea).","date":"2021","source":"Free radical biology & medicine","url":"https://pubmed.ncbi.nlm.nih.gov/34116177","citation_count":26,"is_preprint":false},{"pmid":"36653731","id":"PMC_36653731","title":"Genome-wide identification and expression analysis of metal tolerance protein (MTP) gene family in soybean (Glycine max) under heavy metal stress.","date":"2023","source":"Molecular biology reports","url":"https://pubmed.ncbi.nlm.nih.gov/36653731","citation_count":25,"is_preprint":false},{"pmid":"23043934","id":"PMC_23043934","title":"Novel mutations in SAR1B and MTTP genes in Tunisian children with chylomicron retention disease and abetalipoproteinemia.","date":"2012","source":"Gene","url":"https://pubmed.ncbi.nlm.nih.gov/23043934","citation_count":25,"is_preprint":false},{"pmid":"25921304","id":"PMC_25921304","title":"Sin3A-associated protein, 18 kDa, a novel binding partner of TRIB1, regulates MTTP expression.","date":"2015","source":"Journal of lipid research","url":"https://pubmed.ncbi.nlm.nih.gov/25921304","citation_count":24,"is_preprint":false},{"pmid":"17854051","id":"PMC_17854051","title":"Functional analysis of promoter variants in the microsomal triglyceride transfer protein (MTTP) gene.","date":"2008","source":"Human mutation","url":"https://pubmed.ncbi.nlm.nih.gov/17854051","citation_count":24,"is_preprint":false},{"pmid":"19496770","id":"PMC_19496770","title":"A non-synonymous mutation in a conserved site of the MTTP gene is strongly associated with protein activity and fatty acid profile in pigs.","date":"2009","source":"Animal genetics","url":"https://pubmed.ncbi.nlm.nih.gov/19496770","citation_count":24,"is_preprint":false},{"pmid":"32800239","id":"PMC_32800239","title":"Identification of MTP gene family in tea plant (Camellia sinensis L.) and characterization of CsMTP8.2 in manganese toxicity.","date":"2020","source":"Ecotoxicology and environmental safety","url":"https://pubmed.ncbi.nlm.nih.gov/32800239","citation_count":24,"is_preprint":false},{"pmid":"27371118","id":"PMC_27371118","title":"Disturbance of mitochondrial functions provoked by the major long-chain 3-hydroxylated fatty acids accumulating in MTP and LCHAD deficiencies in skeletal muscle.","date":"2016","source":"Toxicology in vitro : an international journal published in association with BIBRA","url":"https://pubmed.ncbi.nlm.nih.gov/27371118","citation_count":24,"is_preprint":false},{"pmid":"11427523","id":"PMC_11427523","title":"Binding of microsomal triglyceride transfer protein to lipids results in increased affinity for apolipoprotein B: evidence for stable microsomal MTP-lipid complexes.","date":"2001","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/11427523","citation_count":24,"is_preprint":false},{"pmid":"25108285","id":"PMC_25108285","title":"Novel missense MTTP gene mutations causing abetalipoproteinemia.","date":"2014","source":"Biochimica et biophysica acta","url":"https://pubmed.ncbi.nlm.nih.gov/25108285","citation_count":23,"is_preprint":false},{"pmid":"17855359","id":"PMC_17855359","title":"Conditional intestinal lipotoxicity in Apobec-1-/- Mttp-IKO mice: a survival advantage for mammalian intestinal apolipoprotein B mRNA editing.","date":"2007","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/17855359","citation_count":23,"is_preprint":false},{"pmid":"17158677","id":"PMC_17158677","title":"Biochemical and genetic analysis of the gamma-resorcylate (2,6-dihydroxybenzoate) catabolic pathway in Rhizobium sp. strain MTP-10005: identification and functional analysis of its gene cluster.","date":"2006","source":"Journal of bacteriology","url":"https://pubmed.ncbi.nlm.nih.gov/17158677","citation_count":23,"is_preprint":false},{"pmid":"28260075","id":"PMC_28260075","title":"Protective effect of mitochondria‑targeted peptide MTP‑131 against oxidative stress‑induced apoptosis in RGC‑5 cells.","date":"2017","source":"Molecular medicine reports","url":"https://pubmed.ncbi.nlm.nih.gov/28260075","citation_count":23,"is_preprint":false},{"pmid":"7650390","id":"PMC_7650390","title":"Comparative studies of cytotoxicity and the release of TNF-alpha, nitric oxide, and eicosanoids of liver macrophages treated with lipopolysaccharide and liposome-encapsulated MTP-PE.","date":"1995","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/7650390","citation_count":23,"is_preprint":false},{"pmid":"35771993","id":"PMC_35771993","title":"Long Noncoding RNA lncRHL Regulates Hepatic VLDL Secretion by Modulating hnRNPU/BMAL1/MTTP Axis.","date":"2022","source":"Diabetes","url":"https://pubmed.ncbi.nlm.nih.gov/35771993","citation_count":22,"is_preprint":false},{"pmid":"12177174","id":"PMC_12177174","title":"Regulation of MTP expression in developing swine.","date":"2002","source":"Journal of lipid research","url":"https://pubmed.ncbi.nlm.nih.gov/12177174","citation_count":22,"is_preprint":false},{"pmid":"15741653","id":"PMC_15741653","title":"Hypolipidemic action of the SERM acolbifene is associated with decreased liver MTP and increased SR-BI and LDL receptors.","date":"2005","source":"Journal of lipid research","url":"https://pubmed.ncbi.nlm.nih.gov/15741653","citation_count":22,"is_preprint":false},{"pmid":"22496539","id":"PMC_22496539","title":"Distinguishing between longevity and buffered-deleterious genotypes for exceptional human longevity: the case of the MTP gene.","date":"2012","source":"The journals of gerontology. Series A, Biological sciences and medical sciences","url":"https://pubmed.ncbi.nlm.nih.gov/22496539","citation_count":22,"is_preprint":false},{"pmid":"27170061","id":"PMC_27170061","title":"MTP Gene Variants and Response to Lomitapide in Patients with Homozygous Familial Hypercholesterolemia.","date":"2016","source":"Journal of atherosclerosis and thrombosis","url":"https://pubmed.ncbi.nlm.nih.gov/27170061","citation_count":21,"is_preprint":false},{"pmid":"32907986","id":"PMC_32907986","title":"Membrane-bound sn-1,2-diacylglycerols explain the dissociation of hepatic insulin resistance from hepatic steatosis in MTTP knockout mice.","date":"2020","source":"Journal of lipid research","url":"https://pubmed.ncbi.nlm.nih.gov/32907986","citation_count":21,"is_preprint":false},{"pmid":"26784701","id":"PMC_26784701","title":"Camphene, a Plant Derived Monoterpene, Exerts Its Hypolipidemic Action by Affecting SREBP-1 and MTP Expression.","date":"2016","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/26784701","citation_count":21,"is_preprint":false},{"pmid":"1431559","id":"PMC_1431559","title":"Liposomes containing muramyl tripeptide phosphatidylethanolamine (MTP-PE) are excellent adjuvants for induction of an immune response to protein and tumor antigens.","date":"1992","source":"Journal of leukocyte biology","url":"https://pubmed.ncbi.nlm.nih.gov/1431559","citation_count":21,"is_preprint":false},{"pmid":"15723548","id":"PMC_15723548","title":"Oleate-mediated stimulation of microsomal triglyceride transfer protein (MTP) gene promoter: implications for hepatic MTP overexpression in insulin resistance.","date":"2005","source":"Biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/15723548","citation_count":20,"is_preprint":false},{"pmid":"24333444","id":"PMC_24333444","title":"Mechanisms underlying hypertriglyceridemia in rats with monosodium L-glutamate-induced obesity: evidence of XBP-1/PDI/MTP axis activation.","date":"2013","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/24333444","citation_count":20,"is_preprint":false},{"pmid":"30029694","id":"PMC_30029694","title":"Fatal pitfalls in newborn screening for mitochondrial trifunctional protein (MTP)/long-chain 3-Hydroxyacyl-CoA dehydrogenase (LCHAD) deficiency.","date":"2018","source":"Orphanet journal of rare diseases","url":"https://pubmed.ncbi.nlm.nih.gov/30029694","citation_count":20,"is_preprint":false},{"pmid":"21394827","id":"PMC_21394827","title":"A severe form of abetalipoproteinemia caused by new splicing mutations of microsomal triglyceride transfer protein (MTTP).","date":"2011","source":"Human mutation","url":"https://pubmed.ncbi.nlm.nih.gov/21394827","citation_count":20,"is_preprint":false},{"pmid":"26267806","id":"PMC_26267806","title":"Microsomal Triglyceride Transfer Protein (MTP) Associates with Cytosolic Lipid Droplets in 3T3-L1 Adipocytes.","date":"2015","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/26267806","citation_count":19,"is_preprint":false},{"pmid":"23145105","id":"PMC_23145105","title":"Intestine-specific Mttp deletion decreases mortality and prevents sepsis-induced intestinal injury in a murine model of Pseudomonas aeruginosa pneumonia.","date":"2012","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/23145105","citation_count":19,"is_preprint":false},{"pmid":"22074108","id":"PMC_22074108","title":"HBV inhibits apoB production via the suppression of MTP expression.","date":"2011","source":"Lipids in health and disease","url":"https://pubmed.ncbi.nlm.nih.gov/22074108","citation_count":19,"is_preprint":false},{"pmid":"25501226","id":"PMC_25501226","title":"Correlation between MTP -493G>T polymorphism and non-alcoholic fatty liver disease risk: a meta-analysis.","date":"2014","source":"Genetics and molecular research : GMR","url":"https://pubmed.ncbi.nlm.nih.gov/25501226","citation_count":18,"is_preprint":false},{"pmid":"19546343","id":"PMC_19546343","title":"Allele-specific regulation of MTTP expression influences the risk of ischemic heart disease.","date":"2010","source":"Journal of lipid research","url":"https://pubmed.ncbi.nlm.nih.gov/19546343","citation_count":18,"is_preprint":false},{"pmid":"17394061","id":"PMC_17394061","title":"Nonalcoholic steatohepatitis (NASH) in ob/ob mice treated with yo jyo hen shi ko (YHK): effects on peroxisome proliferator-activated receptors (PPARs) and microsomal triglyceride transfer protein (MTP).","date":"2007","source":"Digestive diseases and sciences","url":"https://pubmed.ncbi.nlm.nih.gov/17394061","citation_count":18,"is_preprint":false},{"pmid":"37093290","id":"PMC_37093290","title":"QTL-seq and transcriptomic integrative analyses reveal two positively regulated genes that control the low-temperature germination ability of MTP-maize introgression lines.","date":"2023","source":"TAG. Theoretical and applied genetics. Theoretische und angewandte Genetik","url":"https://pubmed.ncbi.nlm.nih.gov/37093290","citation_count":18,"is_preprint":false},{"pmid":"7908934","id":"PMC_7908934","title":"Liposomal muramyl tripeptide phosphatidylethanolamine (MTP-PE) promotes haemopoietic recovery in irradiated mouse.","date":"1994","source":"International journal of radiation biology","url":"https://pubmed.ncbi.nlm.nih.gov/7908934","citation_count":18,"is_preprint":false},{"pmid":"21316344","id":"PMC_21316344","title":"Acute suppression of apo B secretion by insulin occurs independently of MTP.","date":"2011","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/21316344","citation_count":18,"is_preprint":false},{"pmid":"24588800","id":"PMC_24588800","title":"MTP -493G>T polymorphism and susceptibility to nonalcoholic fatty liver disease: a meta-analysis.","date":"2014","source":"DNA and cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/24588800","citation_count":16,"is_preprint":false},{"pmid":"34516972","id":"PMC_34516972","title":"Cadmium induces triglyceride levels via microsomal triglyceride transfer protein (MTTP) accumulation caused by lysosomal deacidification regulated by endoplasmic reticulum (ER) Ca2+ homeostasis.","date":"2021","source":"Chemico-biological interactions","url":"https://pubmed.ncbi.nlm.nih.gov/34516972","citation_count":16,"is_preprint":false},{"pmid":"15380200","id":"PMC_15380200","title":"5-Carboxamido-1,3,2-dioxaphosphorinanes, potent inhibitors of MTP.","date":"2004","source":"Bioorganic & medicinal chemistry letters","url":"https://pubmed.ncbi.nlm.nih.gov/15380200","citation_count":16,"is_preprint":false},{"pmid":"18280132","id":"PMC_18280132","title":"The influence of polymorphism of -493G/T MTP gene promoter and metabolic syndrome on lipids, fatty acids and oxidative stress.","date":"2008","source":"The Journal of nutritional biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/18280132","citation_count":16,"is_preprint":false},{"pmid":"22355095","id":"PMC_22355095","title":"Rescue of Mtp siRNA-induced hepatic steatosis by DGAT2 siRNA silencing.","date":"2012","source":"Journal of lipid research","url":"https://pubmed.ncbi.nlm.nih.gov/22355095","citation_count":15,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":53381,"output_tokens":6630,"usd":0.129797,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":15821,"output_tokens":6136,"usd":0.116252,"stage2_stop_reason":"end_turn"},"total_usd":0.246049,"stage1_batch_id":"msgbatch_013a8chtv3AWyTqv4z4sEF4C","stage2_batch_id":"msgbatch_01AHsuW63vinsvuTgzmQ3n62","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1998,\n      \"finding\": \"Small molecule inhibitors of MTP prevent assembly and secretion of apolipoprotein B-containing lipoproteins in rodent models, establishing MTP as essential for VLDL/chylomicron production and demonstrating that pharmacological inhibition normalizes plasma lipoprotein levels in WHHL rabbits.\",\n      \"method\": \"High-throughput screening for MTP inhibitors; in vivo treatment of rodent models and WHHL rabbits with compound 9\",\n      \"journal\": \"Science\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1/2 / Strong — in vitro MTP inhibition assay combined with in vivo animal model, replicated across multiple species with clear mechanistic readout\",\n      \"pmids\": [\"9784135\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1999,\n      \"finding\": \"Hepatic overexpression of MTP via recombinant adenovirus in mice results in increased microsomal triglyceride transfer activity, elevated plasma TG, and significantly higher VLDL-TG and VLDL-apoB secretion rates, establishing MTP as rate-limiting for VLDL apoB secretion under basal conditions.\",\n      \"method\": \"Adenoviral hepatic overexpression of MTP in C57BL/6 mice; in vivo measurement of hepatic TG secretion rates and VLDL apoB secretion\",\n      \"journal\": \"Journal of lipid research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — clean gain-of-function in vivo with quantified mechanistic readout (secretion rates), multiple lipid parameters measured\",\n      \"pmids\": [\"10553017\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2000,\n      \"finding\": \"MTP physically interacts with apoB, and a compound (AGI-S17) that specifically inhibits apoB-MTP binding (without affecting MTP lipid transfer activity) reduces apoB secretion by 70-85% in HepG2 cells, identifying two functionally independent domains in MTP: an apoB-binding (chaperone) domain and a lipid transfer domain.\",\n      \"method\": \"Competitive binding assays with apoB peptides and MTP; co-immunoprecipitation in HepG2 cells; selective inhibitor (AGI-S17 vs BMS-200150); apoB secretion measurement by pulse-chase\",\n      \"journal\": \"Biochemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — reciprocal inhibitor approach distinguishing two functional domains, co-IP in cells, secretion assay with multiple controls\",\n      \"pmids\": [\"10769147\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"MTP binds lipid vesicles to form stable MTP-lipid complexes in the ER lumen; binding of MTP to zwitterionic phospholipids increases its affinity for apoB100 2–4-fold, while negatively charged lipids decrease apoB-MTP interactions. Stable MTP-lipid complexes are detected in microsomal fractions of COS cells, HepG2 cells, and mouse liver.\",\n      \"method\": \"In vitro lipid binding and protein-protein interaction assays; ultracentrifugation of microsomal contents; binding affinity measurements with apoB truncation constructs\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — in vitro reconstitution of MTP-lipid complexes plus cellular fractionation, multiple apoB constructs tested, results replicated in three cell/tissue systems\",\n      \"pmids\": [\"11427523\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"Conditional intestine-specific deletion of Mttp in villus enterocytes abolishes chylomicron assembly and secretion, causes enterocyte lipid droplet accumulation (steatorrhea), and dramatically reduces apoB48 secretion; hepatic lipogenesis and VLDL secretion increase compensatorily, establishing MTTP as essential for intestinal chylomicron assembly.\",\n      \"method\": \"Tamoxifen-inducible intestine-specific Cre-lox knockout (Mttp-IKO); electron microscopy; in vivo chylomicron secretion assays; primary enterocyte apoB48 secretion\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — clean conditional KO with multiple orthogonal phenotypic readouts and in vivo/in vitro validation\",\n      \"pmids\": [\"16354657\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"MTP (via a novel splice variant MTPv1 expressed from an alternate promoter in thymocytes) transfers phosphatidylethanolamine to CD1d in vitro and is required for NKT cell development; MTP inhibition in fetal thymic organ culture abolishes CD1d tetramer-positive cell generation and IL-4 production, while CD1d surface expression is unaffected.\",\n      \"method\": \"PCR/Northern analysis identifying MTPv1; Edman degradation of isolated MTPv1; in vitro phospholipid transfer to CD1d; fetal thymic organ culture with MTP antagonists; flow cytometry for CD1d tetramers\",\n      \"journal\": \"The Journal of experimental medicine\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1/2 / Strong — in vitro lipid transfer reconstitution to CD1d, loss-of-function FTOC experiment, multiple orthogonal methods in single study\",\n      \"pmids\": [\"17312007\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"IRE1β (but not IRE1α) selectively degrades MTP mRNA via increased posttranscriptional degradation in enterocytes, thereby reducing intestinal MTP expression and chylomicron production; Ire1b−/− mice secrete more chylomicrons and express more intestinal (but not hepatic) MTP.\",\n      \"method\": \"Ire1b−/− mouse model; diet challenge; primary enterocyte isolation; cell culture siRNA knockdown of IRE1β; quantification of MTP mRNA stability and chylomicron secretion\",\n      \"journal\": \"Cell metabolism\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — genetic KO with in vivo phenotype, primary cells, and cell culture mechanistic follow-up; IRE1α/β specificity established\",\n      \"pmids\": [\"18460335\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"The circadian clock gene CLOCK upregulates SHP (NROB2) expression by binding to its E-box; SHP then suppresses MTP expression by binding to HNF4α/LRH-1 at the MTP promoter, establishing a CLOCK→SHP→MTP axis that drives diurnal oscillation of plasma triglyceride-rich lipoproteins.\",\n      \"method\": \"Clock mutant mice (Clock mt/mt); CLOCK knockdown; SHP knockout mice (Shp−/−); serum-shock cyclic expression assay; promoter binding and siRNA experiments; rescue of hypertriglyceridemia by SHP expression\",\n      \"journal\": \"Cell metabolism\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — multiple genetic models (KO, knockdown, mutant), epistasis rescue experiment, promoter interaction studies, replicated in vivo phenotype\",\n      \"pmids\": [\"20674862\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"The IRE1α-XBP1s arm of the UPR regulates hepatic VLDL assembly: hepatocyte-specific Ire1α deletion reduces MTP activity (without affecting TG synthesis or apoB synthesis/secretion) due to decreased PDI expression, impairing lipid partitioning into the ER lumen and TG-rich VLDL assembly.\",\n      \"method\": \"Hepatocyte-specific Ire1α knockout mice; MTP activity assays; de novo lipogenesis measurements; apoB synthesis/secretion assays; PDI expression analysis\",\n      \"journal\": \"Cell metabolism\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — conditional KO with mechanistic dissection of multiple pathway steps, multiple orthogonal readouts, establishes IRE1α-XBP1s-PDI-MTP axis\",\n      \"pmids\": [\"23040069\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"NR2F1 suppresses synergistic activation of the MTTP promoter by HNF-4α/HNF-1α by binding to a direct repeat 1 (DR1) element and recruiting nuclear receptor corepressor 1 (NCoR1), without affecting activities of the individual transcription factors; HNF-4α is required for basal MTTP expression.\",\n      \"method\": \"MTTP promoter-reporter (luciferase) assays; EMSA; co-transfection of transcription factors in intestinal cell lines\",\n      \"journal\": \"Journal of lipid research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — promoter-reporter and EMSA in cell culture, single lab, mechanistically defines a novel repression mechanism\",\n      \"pmids\": [\"22357705\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"FoxO6 directly binds the MTP promoter and stimulates MTP expression and VLDL-TG secretion; insulin inhibits this by phosphorylating FoxO6 to disable DNA binding. Hepatic FoxO6 inhibition in insulin-resistant db/db mice suppresses MTP expression and reduces hypertriglyceridemia.\",\n      \"method\": \"Transgenic and knockdown mouse models; promoter binding assays (ChIP-like); MTP promoter-reporter assays with FoxO6 site mutations; primary human hepatocytes; insulin signaling assays in db/db mice\",\n      \"journal\": \"Endocrinology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — gain-of-function and loss-of-function in multiple models (transgenic mice, KD, db/db), promoter mutagenesis, functional rescue, and primary human cells\",\n      \"pmids\": [\"24437489\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"SAP18 is a novel binding partner of TRIB1 that regulates MTTP expression; SAP18 and TRIB1 co-occupy MTTP regulatory sequences along with mSin3A; SAP18 knockdown decreases and overexpression increases hepatic MTTP expression and plasma lipid levels.\",\n      \"method\": \"Yeast two-hybrid screen; adenoviral overexpression/knockdown in mouse liver; chromatin immunoprecipitation; transcriptome analysis\",\n      \"journal\": \"Journal of lipid research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — ChIP, in vivo gain- and loss-of-function, single lab with multiple methods\",\n      \"pmids\": [\"25921304\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"Loss of MTTP activity (MTTPR46G mutation) in iPSC-derived hepatocytes and cardiomyocytes abolishes apoB secretion and causes intracellular lipid accumulation and increased cell death in cardiomyocytes; correction of the mutation by CRISPR/Cas9 rescues these phenotypes, demonstrating a cell-autonomous requirement for MTTP in both cell types.\",\n      \"method\": \"Patient-derived iPSCs with MTTPR46G mutation; differentiation to hepatocytes and cardiomyocytes; CRISPR/Cas9 correction; apoB secretion assays; lipid staining; cell death assays\",\n      \"journal\": \"Cell reports\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — isogenic CRISPR rescue controls in two cell types, multiple functional readouts, clean loss-of-function with genetic correction\",\n      \"pmids\": [\"28514664\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"PRAP1 is a novel lipid-binding protein that directly binds TG and forms a ternary complex with TG and MTTP in the ER; a single amino acid mutation (E85V) that disrupts ternary complex formation impairs MTTP-mediated apoB-containing lipoprotein assembly and secretion. PRAP1-deficient and E85V knock-in mice show reduced lipid absorption and resistance to diet-induced obesity.\",\n      \"method\": \"Co-localization in ER; in vitro lipid transfer assays; ternary complex formation assays; site-directed mutagenesis (E85V); PRAP1-KO and knock-in mouse models; high-fat diet challenge\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — in vitro reconstitution of ternary complex, mutagenesis, and multiple in vivo genetic models with clear mechanistic phenotype\",\n      \"pmids\": [\"33168624\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"In liver-specific MTTP knockout (L-Mttp−/−) mice, hepatic steatosis does not cause insulin resistance in young mice because DAG accumulates in lipid droplets rather than the plasma membrane; in aged L-Mttp−/− mice, plasma membrane sn-1,2-DAG content increases with PKCε activation and hepatic insulin resistance, demonstrating that intracellular DAG compartmentalization determines insulin sensitivity independent of steatosis.\",\n      \"method\": \"Liver-specific Mttp KO mice; hyperinsulinemic-euglycemic clamps; subcellular DAG fractionation; PKCε activation assay; mitochondrial uncoupler treatment\",\n      \"journal\": \"Journal of lipid research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — conditional KO with clamp studies, subcellular fractionation, and pharmacological rescue providing mechanistic pathway placement\",\n      \"pmids\": [\"32907986\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"The MTTP promoter polymorphism -164T>C mediates allele-specific promoter activity: the common -164T allele shows lower transcriptional activity than the rare -164C allele. EMSA revealed higher binding of transcription factor SREBP1a to the -164T probe, suggesting that SREBP1a binding to this site reduces MTTP promoter activity.\",\n      \"method\": \"Promoter-reporter (luciferase) assays in Huh-7 hepatoma cells; EMSA with SREBP1a\",\n      \"journal\": \"Human mutation\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — luciferase reporter with multiple haplotype constructs and EMSA, single lab\",\n      \"pmids\": [\"17854051\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"Oleic acid directly stimulates MTP gene transcription in HepG2 cells through a region between -116 and -109 bp of the MTP promoter in an SRE-independent manner; palmitate, arachidonic acid, and linoleic acid do not stimulate MTP transcription.\",\n      \"method\": \"MTP promoter-luciferase reporter assays with deletion/mutation constructs in HepG2 cells; long-term oleic acid treatment with MTP mRNA quantification\",\n      \"journal\": \"Biochemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — promoter deletion mapping and promoter mutagenesis with fatty acid specificity controls, single lab\",\n      \"pmids\": [\"15723548\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"Hepatitis B virus (HBV) infection suppresses MTP mRNA and protein expression in a dose-dependent manner in transfected HepG2 cells, leading to decreased apoB expression and secretion.\",\n      \"method\": \"HBV infectious clone (pHBV1.3) transfection in HepG2 cells; RT-PCR and western blot for MTP and apoB\",\n      \"journal\": \"Lipids in health and disease\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 / Weak — single lab, single transfection model, no mechanistic pathway identified beyond expression reduction\",\n      \"pmids\": [\"22074108\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"Acute insulin suppression of apoB secretion occurs independently of MTP: insulin does not alter hepatic MTP mRNA levels or lipid transfer activity acutely (2h) in vivo, and overexpression of MTP does not abrogate insulin-mediated suppression of apoB secretion in primary rat hepatocytes.\",\n      \"method\": \"In vivo insulin injection in apobec-1−/− mice; adenoviral MTP overexpression in primary rat hepatocytes; MTP lipid transfer activity assays; apoB secretion measurement\",\n      \"journal\": \"Biochemical and biophysical research communications\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — in vivo and in vitro approaches with gain-of-function, establishes negative result (MTP-independent acute insulin effect) rigorously\",\n      \"pmids\": [\"21316344\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"Missense mutations Y528H and R540C in MTTP cause abetalipoproteinemia by abolishing lipid-transfer activity while retaining normal binding to PDI and apoB; N649S partially reduces activity; G264R retains full activity but causes ABL via a frameshift, identifying the region containing residues 528-540 as critical for the lipid-transfer catalytic domain.\",\n      \"method\": \"Transient expression in COS-7 cells; MTP lipid-transfer activity assays; co-immunoprecipitation with PDI and apoB constructs\",\n      \"journal\": \"Biochimica et biophysica acta\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1/2 / Moderate — in vitro activity assay with mutagenesis panel, single lab\",\n      \"pmids\": [\"25108285\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"MTTP splicing mutations causing exon deletions (Δ6 and Δ10) produce truncated proteins that fail to bind PDI and lack triglyceride transfer activity, but still localize normally to the ER, demonstrating that PDI binding and lipid transfer activity are not required for ER retention of MTTP.\",\n      \"method\": \"Minigene splicing reporter assays; transfection in HepG2/HeLa cells; PDI co-immunoprecipitation; ER localization by immunofluorescence; triglyceride transfer activity assay on duodenal biopsies\",\n      \"journal\": \"Human mutation\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — functional assay on patient biopsies plus cell-based mechanistic studies with multiple readouts, single lab\",\n      \"pmids\": [\"22236406\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"MTP associates with cytosolic lipid droplet surfaces in adipocytes and fatty liver hepatocytes, redistributing from the juxtanuclear ER region to lipid droplets during 3T3-L1 adipocyte differentiation; MTP co-localizes with but does not overlap with perilipin 2 on droplets; inhibition of MTP activity does not affect TG export via lipolysis or secretion from adipocytes.\",\n      \"method\": \"Immunofluorescence microscopy; subcellular fractionation; MTP inhibitor treatment; lipid droplet isolation; differentiation time-course in 3T3-L1 cells\",\n      \"journal\": \"PloS one\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 / Moderate — localization by microscopy and fractionation confirmed in adipocytes and human liver, negative functional result explicitly tested, single lab\",\n      \"pmids\": [\"26267806\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"High-fat diet-induced NAFLD in rats is associated with elevated DNA methylation of the MTTP promoter (at specific CpG sites including -113 and -20), which negatively correlates with MTTP expression; berberine reverses this methylation and restores MTTP expression and hepatic TG export.\",\n      \"method\": \"Bisulfite sequencing of MTTP promoter CpG sites; MTTP mRNA quantification; hepatic TG secretion measurement in high-fat diet rats treated with berberine\",\n      \"journal\": \"Journal of lipid research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — correlation of promoter methylation with expression plus interventional reversal experiment, single lab\",\n      \"pmids\": [\"20567026\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"Lipid overload activates PKCδ via oxidative stress, which prevents HNF4α nuclear entry, reducing MTP transcription and impairing VLDL secretion in hepatocytes; PKCδ inhibitor (Go6983) or ROS scavenger (NAC) partially rescues MTP expression and VLDL secretion.\",\n      \"method\": \"In vivo high-fat diet in large yellow croaker; in vitro oleic acid treatment of hepatocytes; PKCδ inhibitor and NAC treatments; HNF4α nuclear localization assays; MTP expression and VLDL secretion measurements\",\n      \"journal\": \"Free radical biology & medicine\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — in vivo and in vitro model with pharmacological rescue, mechanistic pathway (oxidative stress-PKCδ-HNF4α-MTP) established, single lab\",\n      \"pmids\": [\"34116177\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"Adipocyte-derived exosomal MTTP enters CRC cells and forms a complex with PRAP1 that inhibits ZEB1 expression and upregulates GPX4 and xCT, reducing polyunsaturated fatty acid ratios and lipid ROS levels to suppress ferroptosis and promote chemoresistance to oxaliplatin.\",\n      \"method\": \"Exosome isolation and characterization; co-IP of MTTP-PRAP1 complex; siRNA knockdown and MTTP inhibitor experiments; organoid models; obese mouse tumor implantation model; lipid ROS measurement\",\n      \"journal\": \"Advanced science\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — co-IP, organoid, and in vivo model, multiple pathway components tested, single lab\",\n      \"pmids\": [\"35978266\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"Cadmium exposure increases MTTP protein stability by inhibiting both proteasomal and lysosomal protein degradation pathways; the lysosomal pathway is disrupted via ER Ca2+ release through IP3R, and this Ca2+-dependent lysosomal deacidification leads to MTTP accumulation and elevated TG secretion.\",\n      \"method\": \"siRNA knockdown of MTTP; co-treatment with proteasome inhibitor MG132 and lysosome inhibitor CQ; intracellular Ca2+ chelation (BAPTA/AM); IP3R inhibition (2-APB); SERCA activation (CDN1163); TG and MTTP protein measurement in HepG2 cells\",\n      \"journal\": \"Chemico-biological interactions\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — pharmacological pathway dissection with multiple orthogonal inhibitors, single lab\",\n      \"pmids\": [\"34516972\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"MTTP (microsomal triglyceride transfer protein) is an ER-resident lipid transfer protein that forms a heterodimer with PDI and is essential for lipidating nascent apoB during VLDL and chylomicron assembly; it possesses functionally distinct apoB-binding (chaperone) and lipid-transfer catalytic domains, transfers neutral lipids and phospholipids (including phosphatidylethanolamine to CD1d for NKT cell development), associates with stable MTP-lipid complexes in the ER lumen that enhance apoB affinity, is transcriptionally regulated by HNF4α/HNF1α (activated), SHP/CLOCK (circadian repression), FoxO6 (insulin-sensitive activation), NR2F1/NCoR1 (repression), and SREBP1a (allele-specific), is post-transcriptionally regulated by IRE1β-mediated mRNA degradation in enterocytes and by IRE1α-XBP1s-PDI activity in hepatocytes, and can localize to cytosolic lipid droplet surfaces in adipocytes and steatotic hepatocytes.\"\n}\n```","stage2_raw":"{\n  \"mechanistic_narrative\": \"MTTP (microsomal triglyceride transfer protein) is an endoplasmic reticulum lipid-transfer protein that is essential and rate-limiting for the assembly and secretion of apolipoprotein B-containing lipoproteins, including hepatic VLDL and intestinal chylomicrons [#0, #1, #4]. It carries two functionally separable activities: an apoB-binding (chaperone) domain that physically engages nascent apoB, and an independent lipid-transfer catalytic domain, since a selective inhibitor of apoB-MTP binding blocks apoB secretion without affecting lipid transfer [#2], and abetalipoproteinemia-causing mutations (Y528H, R540C) abolish lipid-transfer activity while retaining normal binding to PDI and apoB [#19]. MTP binds phospholipid vesicles to form stable ER-luminal MTP-lipid complexes, with zwitterionic phospholipids increasing apoB100 affinity 2-4 fold and negatively charged lipids reducing it [#3], and it forms a ternary complex with the TG-binding protein PRAP1 that is required for efficient apoB-lipoprotein assembly [#13]. Tissue-specific loss-of-function studies establish a cell-autonomous requirement: intestinal deletion abolishes chylomicron assembly and causes enterocyte lipid accumulation [#4], and patient-derived MTTP-mutant hepatocytes and cardiomyocytes fail to secrete apoB and accumulate lipid, phenotypes rescued by CRISPR correction [#12]. Beyond bulk neutral-lipid transfer, an alternately promoted splice variant (MTPv1) transfers phosphatidylethanolamine to CD1d and is required for NKT cell development [#5]. MTP expression is tightly controlled transcriptionally by HNF4\\u03b1/HNF1\\u03b1 activation opposed by NR2F1/NCoR1 repression [#9], by CLOCK\\u2192SHP circadian repression [#7], and by insulin-sensitive FoxO6 activation [#10], and post-transcriptionally by IRE1\\u03b2-mediated mRNA degradation in enterocytes [#6] and the IRE1\\u03b1-XBP1s-PDI axis in hepatocytes [#8]. Loss of MTTP-dependent lipid export drives intracellular lipid retention whose subcellular compartmentalization, rather than steatosis per se, dictates hepatic insulin sensitivity [#14].\",\n  \"teleology\": [\n    {\n      \"year\": 1998,\n      \"claim\": \"Established that MTP is required for production of apoB-containing lipoproteins, validating it as the assembly machinery and a pharmacological lipid-lowering target.\",\n      \"evidence\": \"Small-molecule MTP inhibitors in rodents and WHHL rabbits, with in vitro MTP assay\",\n      \"pmids\": [\"9784135\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Did not resolve which MTP activity (lipid transfer vs apoB binding) the inhibitors blocked\", \"Did not establish whether MTP is rate-limiting under basal conditions\"]\n    },\n    {\n      \"year\": 1999,\n      \"claim\": \"Showed MTP is rate-limiting for VLDL apoB secretion, not merely permissive, by demonstrating that raising MTP increases lipoprotein output.\",\n      \"evidence\": \"Adenoviral hepatic MTP overexpression in mice with in vivo secretion-rate measurement\",\n      \"pmids\": [\"10553017\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Did not address intestinal/chylomicron pathway\", \"Mechanism of rate limitation at the molecular step not dissected\"]\n    },\n    {\n      \"year\": 2000,\n      \"claim\": \"Resolved MTP into two functionally independent domains by showing apoB binding can be inhibited separately from lipid transfer.\",\n      \"evidence\": \"Competitive binding, co-IP, and a selective apoB-MTP binding inhibitor in HepG2 cells\",\n      \"pmids\": [\"10769147\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Residue-level mapping of the two domains not defined here\", \"Relative contribution of each domain in vivo unquantified\"]\n    },\n    {\n      \"year\": 2001,\n      \"claim\": \"Explained how lipid context modulates MTP function by showing MTP forms ER-luminal MTP-lipid complexes whose phospholipid charge tunes apoB affinity.\",\n      \"evidence\": \"In vitro lipid-binding/interaction assays and microsomal fractionation across COS, HepG2, and mouse liver\",\n      \"pmids\": [\"11427523\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Structural basis of charge-dependent affinity change unknown\", \"In vivo relevance of complex stoichiometry not established\"]\n    },\n    {\n      \"year\": 2005,\n      \"claim\": \"Demonstrated the cell-autonomous, tissue-specific requirement for MTTP in intestinal chylomicron assembly and revealed hepatic compensation.\",\n      \"evidence\": \"Inducible intestine-specific Mttp knockout with EM and in vivo/in vitro secretion assays\",\n      \"pmids\": [\"16354657\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Mechanism of compensatory hepatic lipogenesis not defined\"]\n    },\n    {\n      \"year\": 2007,\n      \"claim\": \"Extended MTP function beyond bulk lipoprotein assembly to immune lipid antigen presentation, showing a splice variant transfers PE to CD1d for NKT development.\",\n      \"evidence\": \"Identification of MTPv1, in vitro PE transfer to CD1d, and MTP antagonist loss-of-function in fetal thymic organ culture\",\n      \"pmids\": [\"17312007\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"In vivo NKT requirement via genetic MTPv1 deletion not shown\", \"Structural basis of CD1d lipid loading by MTP unresolved\"]\n    },\n    {\n      \"year\": 2008,\n      \"claim\": \"Defined post-transcriptional control of MTP, showing IRE1\\u03b2 selectively degrades MTP mRNA in enterocytes to limit chylomicron output.\",\n      \"evidence\": \"Ire1b-/- mice with diet challenge, primary enterocytes, and siRNA knockdown\",\n      \"pmids\": [\"18460335\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Cleavage specificity determinants on MTP mRNA not mapped\", \"Tissue restriction mechanism (intestine vs liver) unexplained\"]\n    },\n    {\n      \"year\": 2008,\n      \"claim\": \"Linked a common MTTP promoter polymorphism to allele-specific transcription via differential SREBP1a binding.\",\n      \"evidence\": \"Promoter-reporter assays and EMSA in Huh-7 cells\",\n      \"pmids\": [\"17854051\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"In vivo physiological impact of the -164T>C allele not established\", \"Whether SREBP1a binding is causally repressive untested in vivo\"]\n    },\n    {\n      \"year\": 2010,\n      \"claim\": \"Connected the circadian clock to lipoprotein rhythms by defining a CLOCK\\u2192SHP\\u2192MTP transcriptional repression axis.\",\n      \"evidence\": \"Clock-mutant and Shp-/- mice, promoter binding, knockdown, and SHP rescue of hypertriglyceridemia\",\n      \"pmids\": [\"20674862\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Quantitative contribution of this axis to total diurnal MTP variation unclear\"]\n    },\n    {\n      \"year\": 2010,\n      \"claim\": \"Implicated epigenetic silencing of MTTP in diet-induced NAFLD and showed it is pharmacologically reversible.\",\n      \"evidence\": \"Bisulfite sequencing and berberine intervention in high-fat-diet rats\",\n      \"pmids\": [\"20567026\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Methyltransferase/demethylase responsible not identified\", \"Causality of methylation vs expression not separated from confounders\"]\n    },\n    {\n      \"year\": 2012,\n      \"claim\": \"Defined NR2F1/NCoR1 as a corepressor module antagonizing HNF4\\u03b1/HNF1\\u03b1 synergy at the MTTP promoter.\",\n      \"evidence\": \"Promoter-reporter, EMSA, and TF co-transfection in intestinal cells\",\n      \"pmids\": [\"22357705\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"In vivo confirmation of NR2F1 repression lacking\", \"Physiological signals controlling NR2F1 occupancy unknown\"]\n    },\n    {\n      \"year\": 2012,\n      \"claim\": \"Defined the IRE1\\u03b1-XBP1s-PDI arm as a hepatic regulator of MTP activity controlling ER lipid partitioning into VLDL.\",\n      \"evidence\": \"Hepatocyte-specific Ire1\\u03b1 knockout with MTP activity, lipogenesis, apoB, and PDI readouts\",\n      \"pmids\": [\"23040069\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether PDI level is the sole limiting factor for MTP activity not isolated\"]\n    },\n    {\n      \"year\": 2012,\n      \"claim\": \"Mapped the lipid-transfer catalytic region by showing ABL mutations Y528H/R540C abolish transfer while preserving PDI and apoB binding.\",\n      \"evidence\": \"Transient expression in COS-7 with lipid-transfer assays and co-IP of mutant panel\",\n      \"pmids\": [\"25108285\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"No high-resolution structure of the catalytic domain provided\", \"Single-lab activity assay without orthogonal confirmation\"]\n    },\n    {\n      \"year\": 2012,\n      \"claim\": \"Separated ER retention from function, showing PDI binding and lipid transfer are dispensable for MTTP ER localization.\",\n      \"evidence\": \"Minigene splicing reporters, PDI co-IP, immunofluorescence, and biopsy transfer assays\",\n      \"pmids\": [\"22236406\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"ER retention signal/determinant not identified\", \"Single-lab study\"]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"Placed MTP under insulin-sensitive transcriptional control via FoxO6, linking insulin resistance to hypertriglyceridemia.\",\n      \"evidence\": \"Transgenic/knockdown and db/db mouse models, promoter mutagenesis, and primary human hepatocytes\",\n      \"pmids\": [\"24437489\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Interplay between FoxO6 and other MTP regulators not integrated\"]\n    },\n    {\n      \"year\": 2015,\n      \"claim\": \"Identified a SAP18/TRIB1/mSin3A regulatory module occupying MTTP regulatory sequences to set hepatic expression and plasma lipids.\",\n      \"evidence\": \"Yeast two-hybrid, adenoviral gain/loss in mouse liver, and ChIP\",\n      \"pmids\": [\"25921304\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Direct vs indirect regulation of MTTP by this complex not fully resolved\", \"Single-lab study\"]\n    },\n    {\n      \"year\": 2015,\n      \"claim\": \"Revealed a non-ER, lipid-droplet-associated localization of MTP in adipocytes and steatotic hepatocytes, though without a defined droplet-export function.\",\n      \"evidence\": \"Immunofluorescence, fractionation, and MTP inhibitor treatment across 3T3-L1 and human liver\",\n      \"pmids\": [\"26267806\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Functional role of droplet-localized MTP unknown\", \"Mechanism of ER-to-droplet redistribution undefined\"]\n    },\n    {\n      \"year\": 2017,\n      \"claim\": \"Provided isogenic genetic proof of cell-autonomous MTTP requirement in human hepatocytes and cardiomyocytes via CRISPR rescue.\",\n      \"evidence\": \"Patient MTTPR46G iPSC-derived cells with CRISPR correction and apoB/lipid/death readouts\",\n      \"pmids\": [\"28514664\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Why cardiomyocytes are particularly vulnerable to lipid accumulation not mechanistically resolved\"]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"Identified PRAP1 as a TG-binding cofactor forming a ternary complex with MTTP required for efficient apoB-lipoprotein assembly and dietary lipid absorption.\",\n      \"evidence\": \"In vitro ternary complex reconstitution, E85V mutagenesis, and PRAP1-KO/knock-in mice on high-fat diet\",\n      \"pmids\": [\"33168624\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Stoichiometry and structural arrangement of the MTTP-PRAP1-TG complex unresolved\"]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"Dissociated steatosis from insulin resistance by showing MTTP-loss-driven DAG compartmentalization, not lipid mass, determines hepatic insulin sensitivity.\",\n      \"evidence\": \"Liver-specific Mttp KO mice with clamps, subcellular DAG fractionation, and PKC\\u03b5 assays\",\n      \"pmids\": [\"32907986\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Determinants of DAG partitioning between droplets and plasma membrane not defined\"]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"Connected lipid-overload oxidative stress to MTP suppression through a PKC\\u03b4-HNF4\\u03b1 axis blocking HNF4\\u03b1 nuclear entry.\",\n      \"evidence\": \"In vivo croaker and in vitro hepatocyte models with PKC\\u03b4 inhibitor and NAC rescue\",\n      \"pmids\": [\"34116177\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Mammalian confirmation limited\", \"Direct PKC\\u03b4-HNF4\\u03b1 phosphorylation event not demonstrated\"]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"Showed environmental cadmium raises MTTP protein stability via IP3R-Ca2+-dependent lysosomal deacidification and proteasomal inhibition, elevating TG secretion.\",\n      \"evidence\": \"Pharmacological dissection (MG132, CQ, BAPTA, 2-APB, CDN1163) with MTTP/TG readouts in HepG2\",\n      \"pmids\": [\"34516972\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"E3 ligase/degradation machinery for MTTP not identified\", \"Single-lab study\"]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"Revealed a non-canonical extracellular role: adipocyte exosomal MTTP-PRAP1 complexes suppress ferroptosis to drive colorectal cancer chemoresistance.\",\n      \"evidence\": \"Exosome isolation, MTTP-PRAP1 co-IP, knockdown/inhibitor, organoids, and obese-mouse tumor model\",\n      \"pmids\": [\"35978266\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Mechanism of MTTP secretion into exosomes unclear\", \"Link from MTTP-PRAP1 to ZEB1/GPX4/xCT not fully mechanistic\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"How MTTP's catalytic and chaperone domains are structurally arranged and coordinate with PRAP1 and ER-luminal lipid complexes during lipoprotein assembly remains unresolved.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"No high-resolution structure of MTTP in the timeline\", \"Stoichiometry of MTTP-lipid and MTTP-PRAP1-TG complexes undefined\", \"Mechanism of ER-to-lipid-droplet and exosomal redistribution unknown\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0008289\", \"supporting_discovery_ids\": [3, 5, 13, 19]},\n      {\"term_id\": \"GO:0140104\", \"supporting_discovery_ids\": [3, 5, 13]},\n      {\"term_id\": \"GO:0044183\", \"supporting_discovery_ids\": [2]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005783\", \"supporting_discovery_ids\": [3, 13, 20]},\n      {\"term_id\": \"GO:0005811\", \"supporting_discovery_ids\": [21]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-1430728\", \"supporting_discovery_ids\": [0, 1, 4]},\n      {\"term_id\": \"R-HSA-8963743\", \"supporting_discovery_ids\": [4, 13]},\n      {\"term_id\": \"R-HSA-74160\", \"supporting_discovery_ids\": [7, 9, 10]}\n    ],\n    \"complexes\": [\n      \"MTP-PDI heterodimer\",\n      \"MTTP-PRAP1-TG ternary complex\"\n    ],\n    \"partners\": [\n      \"APOB\",\n      \"PDI\",\n      \"PRAP1\",\n      \"CD1d\"\n    ],\n    \"other_free_text\": []\n  }\n}","audit_flag":null,"evaluation":{"pairwise":"win","faith_supported":7,"faith_total":7,"faith_pct":100.0}}